Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Nov 30.
Published in final edited form as: Cancer Genomics Proteomics. 2008 Jan-Feb;5(1):1–35.

Global Comparative Gene Expression Analysis of Melanoma Patient Samples, Derived Cell Lines and Corresponding Tumor Xenografts

YAGUANG XI 1, ADAM RIKER 1, LALITA SHEVDE-SAMANT 1, RAJEEV SAMANT 1, CHRISTOPHER MORRIS 1, ELAINE GAVIN 1, OYSTEIN FODSTAD 1,2, JINGFANG JU 1
PMCID: PMC3226839  NIHMSID: NIHMS338556  PMID: 18359977

Abstract

Various in vitro and in vivo experimental models have been used for the discovery of genes and pathways involved in melanoma and other types of cancer. However, in many cases, the results from various tumor models failed to be validated successfully in clinical studies. Limited information is available on how closely these models reflect the in vivo physiological conditions. In this study, a comprehensive genomics approach was used to systematically compare the expression patterns of snap frozen samples obtained from patients with primary melanoma, lymph node metastasis, and distant metastases, and compare these patterns to those of their corresponding cell lines and tumor xenografts in nude mice. The GE Healthcare 20k human genome array was used and the expression data was normalized and analyzed using GeneSpring 7.2 software. Based on the expression analysis, the correlation rate between the snap frozen primary patient samples vs. derived cell lines was 66%, with 1687 differentially expressed genes. The correlation rate between the snap frozen primary patient samples and the tumor xenografts was 75%, with 1,374 differentially expressed genes, and the correlation rate comparing tumor xenografts to derived cell lines ranged between 58% and 84%. These results demonstrated significant gene expression differences between tumor materials with different in vitro and in vivo growth microenvironments. Such studies can help us to distinguish between genes up- or down-regulated as a result of the microenvironment and those stably expressed independently of the tumor milieu. With the extensive use of cell lines and xenografts in cancer research, the information obtained using our approach may help to better interpret results generated from different tumor models by understanding common differences, as well as similarities at the gene expression level, information that may have important practical and biological implications.

Keywords: Melanoma, expression profiling, connexin 43, metastasis


The mortality rate of melanoma patients is still on the rise despite extensive research efforts. Recent technologies applying high throughput genomics to cancer research have been successfully utilized in melanoma research, identifying key molecular gene targets such as microphthalmia-associated transcription factor (MITF), v-raf murine sarcoma viral oncogene homolog B1(BRAF), and neural precursor cell expressed, developmentally down-regulated 9 (NEDD9) (1-5). The molecular and cellular mechanisms of many genes have been successfully validated in vivo. However, in other cases, the functional significance of such targets has failed to be confirmed in vivo, despite a strong in vitro phenotype. This may reflect the intrinsic and/or extrinsic differences in some tumor models used for such studies. In the case of melanoma, it is known that the disease development not only involves genetic and epigenetic changes that take place within the cell, but also involves processes determined collectively by tumor micro-environmental factors, including cell-cell interactions with a plethora of surrounding stromal elements. Currently, very limited information is available in regard to the distinct genetic and epigenetic mechanisms of gene regulation and expression in these models.

Over the years, cancer biologists have utilized many different tumor models in order to gain an improved understanding of the processes involved in human cancer. One of the most important sources of in vitro models that is still in use today is the NCI-60 cell line panel, used for drug screening, target discovery and validation (6-13). However, in many cases, the functional significance of these genes found in vitro is poorly consistent with those identified in in vivo models. It is well-known that the tumor micro-environment can have a tremendous influence upon gene expression (14). Culture conditions and long-term cell passaging are known to greatly change the gene expression patterns for such artificial environments (15, 16). Currently, there is a lack of systematic analysis of the differences among the available research models that are in use. In many cases, the desired phenotype cannot be replicated in vivo due to the intrinsic differences in the model system. Therefore, it is important to understand the fundamental differences of tumor models in different situations in order to inform and guide gene targets and validation efforts.

To systematically address this issue, a comprehensive gene expression profiling-based analysis was employed to investigate the gene expression differences utilizing melanoma as a model system. This is an ideal system for such examination due to the extensive biobanking efforts of the surgical oncologists in obtaining freshly procured samples followed by immediate cryopreservation. Additionally, an attempt was made to grow and expand daughter melanoma cell lines in vitro whenever enough tissue was available. Utilizing these cell lines, further experiments were performed in several xenograft models, comparing the results of each of these tissue samples for evidence of differences in gene expression. In addition, to further validate this approach, a well characterized pair of melanoma cell lines (FEMX-1 and FEMX-V) with different in vivo metastatic potentials and their corresponding tumor xenografts were also used (17).

Materials and Methods

Tumor specimens

Surgically procured tumor samples from patients with primary cutaneous and metastatic melanoma were obtained under an Investigational Review Board (IRB) approved tissue procurement protocol (MCC#13448, IRB#101751; PSM# 990914-JM, 020318-JM). The tumor specimens were macrodissected and cryopreserved within 5 minutes, being careful to avoid any surrounding, non-neoplastic stromal tissue. All the samples were cryopreserved in liquid nitrogen and stored within the Tissue Procurement Laboratory of the Moffitt Cancer Center, securely de-identified through a centralized database.

Cell lines and tissue culture

Freshly excised melanoma samples were placed into culture media RPMI 1640 with 5% FCS. The expansion of daughter cell lines was performed utilizing previously published techniques (18, 19). All the cell lines were split and serially passaged less than 10 times and characterized by flow cytometry and/or cytospin preparation for cellular confirmation of melanoma cell purity (data not shown). Three cell lines were used in this study, one was derived from a primary melanoma, one from a brain metastasis and one from a distant subcutaneous leg metastasis. One of the best characterized melanoma cell lines, FEMX-I, and its derivative, FEMX-V. which were established and described previously were subsequently investigated (17). These paired cell lines were derived a decade ago from the same patient with lymphnode metastatic melanoma. FEMX-I was the first generation of the clonal variants selected by in vivo experiments that exhibited a strongly aggressive capability of metastasis. FEMX-V was derived from the fifth consecutive generation of metastases developing after injection of isolated cells into a recipient mouse. The FEMX-V cells have no metastatic potential (17). The molecular and cellular mechanisms underlying this change in metastatic capacity have not been systematically investigated, but with high throughput gene expression analysis this is now possible. A comprehensive gene expression analysis of the FEMX-I and FEMX-V cells grown in vitro and xenografts in nude mice was performed. These cell lines were incubated at 37°C in a humidified atmosphere of 5% CO2, in RPMI 1640 (Invitrogen Inc. Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (HyClone. Logan, UT, USA). The xenografts were grown as described previously (20). In brief, the cells were detached at 80-90% confluence with 2 mM EDTA or trypsin-EDTA (0.1% trypsin and 2mM EDTA) solution, washed with calcium- and magnesium-free Dulbecco’s phosphate-buffered saline solution (CMF-DPBS), counted using a hemacytometer and resuspended in ice-cold Hank’s balanced salt solution (HBSS) to a final concentration of 107 cells/ml. The cells, 1×106 (0.1 ml), were injected subcutaneously into the scapular region of 3 weeks old, female athymic mice (Harlan Sprague-Dawley, Indianapolis, IN, USA), using a 27 gauge needle affixed to a 1 cc syringe. The tumor size was measured weekly by Vernier calipers. After the mean tumor diameter reached 10 mm, the mice were euthanized and the tumors were removed for further analysis. The animals were maintained under the guidelines of the National Institute of Health and the University of South Alabama. All the protocols were approved by the Institutional Animal Care and Use Committee of the University of South Alabama. Food and water were provided ad libitum.

RNA isolation and purification

The samples were homogenized in Trizol (Invitrogen Inc.). The 100 Ìl of 1-bromo-3-chloropropane (BCP) solution (Molecular Research Center, Inc., Cincinnati, OH, USA) was added to the samples. After 2 minutes vortexing, the samples were incubated for 3 minutes at room temperature. The upper aqueous phase containing the RNA from each sample was transferred to a new tube and centrifuged at 14,000 rpm for 7 minutes. Equal volume of 100% isopropanol (Sigma, St. Louis, MO, USA) was added and precipitation was performed at −80°C for 60 minutes. After centrifuging at 14,000 rpm for 7 minutes at 4°C, the supernatant was removed and 1 ml of 75% ethanol was added for washing. The pellet of each sample was air dried and eluted with nuclease-free water. The samples were treated with DNase to avoid potential DNA contamination, 15 Ìl DNase treatment mix (2 Ìl RQ1 RNase-Free DNase, 11 Ìl RQ1 DNase 10X Reaction Buffer and 2 Ìl RNasin Plus RNase Inhibitor, Promega, Madison, WI, USA) was incubated with each sample in 100 Ìl volume at 37°C for 30 minutes. Then 115 Ìl UltraPureì phenol: chloroform: isoamyl alcohol (25:24:1, Invitrogen Inc.) was added. After 2 minutes of vortexing, the samples were centrifuged at 14,000 rpm for 7 minutes. The upper aqueous phase was carefully taken out and mixed with 2 volumes of 100% ethanol and 1/10 volume of 3M sodium scetate pH 5.5 (Ambion Inc., Austin, TX, USA). The samples were held at room temperature for 15-30 minutes, then centrifuged at 14,000 rpm for 7 minutes. After removing the supernatant, 1 ml of 75% ethanol was added for washing, centrifuging was repeated and then the pellets were air dried. The samples were dissolved in nuclease-free water. A NanoDrop ND-100 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA) was used to determine the concentration of all the samples.

Gene expression analysis via microarray

The CodeLink UniSet Human 20 K Oligo Bioarray (Amersham Biosciences, NJ, USA), containing approximately 20,289 gene probes, was used to generate the gene expression profiles for all the samples examined. The procedure has been described in detail previously (21, 22). In brief, double-stranded cDNAs were generated using 2 Ìg of total RNA from each sample. All the reagents and protocols were provided by GE Healthcare/Amersham Biosciences except for special indication. After purification, the double-stranded cDNAs were used as templates to generate cRNA via an in vitro transcription reaction using T7 RNA polymerase and biotin-11-UTP (Perkin-Elmer, Boston, MA, USA). The biotin-labeled cRNA (10 Ìg) was fragmented and hybridized to the CodeLink UniSet Human 20 K Oligo Bioarray. The arrays were stained with Cy5-streptavadin. After washing, the dried slides were scanned by Axon GenePix Professional 4200A microarray scanner under Genepix Pro 5.1 software (Molecular Devices Corporation, Sunnyvale, CA, USA). The images were grided by Codelink 4.1 software (GE-Healthcare/Amersham Biosciences) and exported to GeneSpring Software 7.2 (Agilent, Palo Alto, CA, USA).

GeneSpring software allows multifilter comparisons using data from different experiments to perform the normalization, the generation of restriction lists and the functional classification of the differentially expressed genes. Utilizing the Cross-Gene Error Model, normalization was applied in two steps: “per chip normalization” in which each measurement was divided by the 50th percentile of all measurements in its array and “per gene normalization” in which all the samples were normalized against the specific samples (controls). The data was filtered by flags. The expression profiles of the different groups were compared using one-way ANOVA with cut-off p<0.05. Comparisons of the gene lists across the different groups were performed using Venn diagrams and clustering function using Genespring.

Statistical analysis

All the statistical analyses were performed by JMP 6.0 software (SAS Institute Inc. Cary, NC, USA). All the normalized data from tumor tissue, cell lines and tumor xenografts were analyzed to determine the correlation coefficient of expression. P-values of <0.05 were interpreted as statistically significant.

Results

Clustering analysis of expression profiles among three sets of melanoma models

The genes clustered from the primary melanoma models (snap frozen, xenograft and cell line) are shown in Figure 1A. Gene clustering analysis showed that the expression profiles of the melanoma cells and those from human xenografts had more similarities in gene expression compared to the freshly procured tumor samples. Venn diagram analysis (Figure 1B) was utilized to discover the overlapping and unique gene sets among the three samples. Between the melanoma xenografts and the snap frozen tissues 5,135 overlapping genes were found and between the melanoma tumor xenografts and the cell lines8,412 overlapping genes were found. The clustering analysis of the models generated from the brain melanoma metastasis (Figure 2A) and Venn diagram analysis (Figure 2B) were also obtained. The clustering analysis showed that the cell lines and the xenografts had more similarities than the original tumor sample. There were 8,151 overlapping genes between the melanoma xenograft and the snap frozen tissues and 8,347 overlapping genes between melanoma tumor xenografts and cell lines. With the models from the distant (leg) metastasis, the clustering analysis (Figure 3A) showed a close similarity between the cell lines and the xenografts compared to the profiles of the melanoma tissue samples. The Venn diagram analysis (Figure 3B) with the distant metastasis model (snap frozen tissue, derived cell line and xenograft) showed 7,737 overlapping genes between the melanoma xenografts and the snap frozen tissues and 7,404 overlapping genes between the melanoma tumor xenografts and the cell lines.

Figure 1.

Figure 1

Clustering analysis of expression of snap frozen primary melanoma, its derived cell line and tumor xenograft (A). The data was filtered by flags. The expression profiles of the different groups were compared using one-way ANOVA with cut-off p<0.05. Comparisons of gene lists across different groups were performed using Venn diagrams and clustering function using Genespring 7.2 (B).

Figure 2.

Figure 2

Clustering analysis of expression of snap frozen brain metastatic melanoma, its derived cell line and tumor xenograft (A). The data was filtered by flags. The expression profiles of the different groups were compared using one-way ANOVA with cut-off p<0.05. Comparisons of gene lists across different groups were performed using Venn diagrams and clustering function using Genespring 7.2 (B).

Figure 3.

Figure 3

Clustering analysis of expression of snap frozen distant (leg) metastatic melanoma, its derived cell line and tumor xenograft (A). The data was filtered by flags. The expression profiles of the different groups were compared using one-way ANOVA with cut-off p<0.05. Comparisons of gene lists across different groups were performed using Venn diagrams and clustering function using Genespring 7.2 (B).

Correlations analysis based on global gene expression profiles

Next, the expression profiles were compared between the snap frozen surgical samples and their derived cell lines and the tumor xenografts based on global gene expression profiles. The weakest correlation was observed with the cell lines and snap frozen surgical tissue samples, having an overall correlation coefficient of r2=0.59 (Figure 4A). The expression profiles between the cell lines and the corresponding tumor xenografts had a correlation coefficient of r2=0.75, based upon the global gene expression profiles, which was the strongest correlation among the different comparisons (Figure 4B). The correlation between the expression profiles of the snap frozen tissue and the xenograft was r2=0.64 (Figure 4C).

Figure 4.

Figure 4

Correlation coefficient analysis of the expression of all normalized data from tumor tissue, cell lines and tumor xenografts. Statistical analysis was performed using JMP 6.0 software (SAS Institute Inc. Cary, NC, USA). P-values of <0.05 were interpreted as statistically significant.

Correlations analysis based on overlapping gene expression profiles

Correlation analysis was also performed based on all the overlapping genes (Figure 5). The correlation coefficient between the melanoma snap frozen tissues and its derived cell lines was r2=0.61 (Figure 5A). The correlation coefficient between the xenograft and the cell line was r2=0.77 (Figure 5B). The correlation coefficient between the tissue and the cell line was r2=0.67 (Figure 5C).

Figure 5.

Figure 5

Correlation coefficient analysis of the expression of all over-lapping genes from tumor tissue, cell lines and tumor xenografts. Statistical analysis was performed using JMP 6.0 software (SAS Institute Inc. Cary, NC, USA). P-values of <0.05 were interpreted as statistically significant.

Validation of prediction models using cell lines and xenografts

Clustering analysis was performed between the FEMX-I and FEMX-V cell lines and their xenografts (Figure 6A and 6B). Venn diagram analysis was conducted and showed that there were 367 differentially regulated genes in the FEMX-I and FEMX-V cells (Table II). In contrast, 763 genes were altered in the corresponding tumor xenografts. A Venn diagram shows 110 overlapping genes (Figure 6B, Table I). Among these, the tumor susceptibility gene 101 (TSG101) was up-regulated in both model systems. There were 653 non-overlapping genes in the xenografts that were uniquely expressed (Table III). Among these, gap junction protein, alpha 1 (connexin 43), was over-expressed >400-fold in the FEMX-I tumor xenografts compared to the FEMX-V tumor xenografts. However, this gene was not found to be significantly different in gene expression for the daughter cell lines.

Figure 6.

Figure 6

Clustering analysis of expression of melanoma cell lines FEMX-I and FEMX-V and their derived tumor xenografts (A). The data was filtered by flags. The expression profiles of the different groups were compared using one-way ANOVA with cut-off p<0.05. Comparisons of gene lists across different groups were performed using Venn diagrams and clustering function using Genespring 7.2 (B).

Table II. Non-overlapping differentially regulated genes comparison between FEMX-I and FEMX-V cell lines.

GenBank ID Common
name
Fold
change
Description Function
Up-regulated
NM_032380 EFG2 36.70 Mitochondrial elongation factor G2 Protein biosynthesis; translational elongation
NM_000175 GPI 36.50 Glucose phosphate isomerase Carbohydrate metabolism; gluconeogenesis; glycolysis;
hemostasis; humoral immune response; neurogenesis
NM_006297 XRCC1 34.50 X-ray repair complementing defective repair
in Chinese hamster cells 1
Single strand break repair
D42045 DCLRE1A 33.33 DNA cross-link repair 1A (PSO2 homolog,
S. cerevisiae)
NM_001990 EYA3 31.14 Eyes absent homolog 3 (Drosophila) Development; metabolism; morphogenesis;
visual perception
NM_016478 HSPC216 28.97 Nuclear interacting partner of anaplastic
lymphoma kinase (ALK)
NM_016355 LOC51202 26.51 DEAD (Asp-Glu-Ala-Asp) box polypeptide 47 RNA metabolism
AL137581 FLJ34497 25.16 Hypothetical protein FLJ34497
D83781 NUP160 25.01 Nucleoporin 160 kDa Mrna-nucleus export; transport
NM_018412 ST7 24.89 Suppression of tumorigenicity 7
NM_016343 CENPF 23.73 Centromere protein F, 350/400ka (mitosin) DNA replication and chromosome cycle;
regulation of mitosis
NM_002627 PFKP 23.39 Phosphofructokinase, platelet Glycolysis
NM_016292 TRAP1 23.35 Heat shock protein 75 Protein folding
NM_021078 GCN5L2 19.94 GCN5 general control of amino-acid
synthesis 5-like 2 (yeast)
Chromatin remodeling; protein amino acid acetylation;
regulation of transcription from Pol II promoter
NM_006819 STIP1 19.65 Stress-induced-phosphoprotein 1
(Hsp70/Hsp90-organizing protein)
Response to stress
NM_020998 MST1 19.49 Macrophage stimulating 1
(hepatocyte growth factor-like)
Blood coagulation; proteolysis and peptidolysis
NM_004922 SEC24C 19.41 SEC24 related gene family, member C
(S. cerevisiae)
ER to Golgi transport; intracellular protein transport
NM_005381 NCL 19.22 Nucleolin Nuclear mrna splicing, via spliceosome
NM_006746 SCML1 18.47 Sex comb on midleg-like 1 (Drosophila) Morphogenesis
NM_018255 ELP2 17.94 Signal transducer and activator of
transcription 3 interacting protein 1
NM_058179 PSA 16.20 Phosphoserine aminotransferase 1 L-serine biosynthesis; metabolism;
pyridoxine biosynthesis
NM_015954 LOC51071 15.69 Unr-interacting protein
AW293890 THRAP3 14.71 Thyroid hormone receptor associated protein 3
NM_006796 AFG3L2 14.56 AFG3 atpase family gene 3-like 2 (yeast) Proteolysis and peptidolysis
NM_007355 HSPCB 14.18 Heat shock 90 kDa protein 1, beta Positive regulation of nitric oxide biosynthesis;
protein folding; response to unfolded protein
NM_016223 PACSIN3 12.76 Protein kinase C and casein
kinase substrate in neurons 3
Endocytosis; negative regulation of endocytosis
NM_002902 RCN2 12.58 Reticulocalbin 2, EF-hand calcium binding domain
NM_014390 p100 11.98 Staphylococcal nuclease domain containing 1 Regulation of transcription, DNA-dependent
NM_013436 NCKAP1 11.88 NCK-associated protein 1 Apoptosis; central nervous system development
NM_019005 FLJ20323 11.71 Hypothetical protein FLJ20323
NM_004315 ASAH 11.63 N-acylsphingosine amidohydrolase
(acid ceramidase) 1
Ceramide metabolism; fatty acid metabolism
NM_000918 P4HB 11.54 Procollagen-proline, 2-oxoglutarate
4-dioxygenase (proline 4-hydroxylase),
beta polypeptide (protein disulfide isomerase;
thyroid hormone binding protein p55)
Electron transport
NM_021149 COTL1 11.50 Coactosin-like 1 (Dictyostelium) Biological_process unknown
NM_000108 DLD 11.47 Dihydrolipoamide dehydrogenase (E3
component of pyruvate dehydrogenase
complex, 2-oxo-glutarate complex, branched
chain keto acid dehydrogenase complex)
Electron transport; energy pathways; glycolysis
NM_016026 ARSDR1 11.24 Retinol dehydrogenase 11 (all-trans and 9-cis) Metabolism; photoreceptor maintenance;
retinol metabolism
NM_003100 SNX2 11.19 Sorting nexin 2 Endocytosis; intracellular protein transport;
intracellular signaling cascade
NM_007178 UNRIP 11.19 Unr-interacting protein
NM_016238 APC7 11.11 Anaphase promoting complex subunit 7 Cytokinesis; mitosis; regulation of cell cycle
NM_006621 AHCYL1 10.74 S-adenosylhomocysteine hydrolase-like 1 One-carbon compound metabolism
BM460564 BAG4 10.71 BCL2-associated athanogene 4
NM_013236 E46L 10.61 Like mouse brain protein E46 Biological_process unknown
NM_001798 CDK2 10.56 Cyclin-dependent kinase 2 G2/M transition of mitotic cell cycle; cytokinesis;
mitosis; positive regulation of cell proliferation;
protein amino acid phosphorylation; regulation of DNA
replication; traversing start control point of
mitotic cell cycle
NM_018899 PCDHAC2 10.48 Protocadherin alpha 5 Cell adhesion; homophilic cell adhesion; neurogenesis
NM_003472 DEK 10.4 DEK oncogene (DNA binding) SRP-dependent cotranslational membrane targeting;
cell growth and/or maintenance; regulation of
transcription from Pol II promoter; signal transduction;
viral genome replication
NM_001415 EIF2S3 10.4 Eukaryotic translation initiation factor 2,
subunit 3 gamma, 52 kDa
Protein biosynthesis
NM_024586 OSBPL9 10.4 Oxysterol binding protein-like 9 Lipid transport; steroid metabolism
AK056156 TMP21 10.36 Transmembrane trafficking protein ER to Golgi transport; intracellular protein transport
NM_015361 R3HDM 10.35 R3H domain (binds single-stranded
nucleic acids) containing
AL050143 DKFZP586B2420 10.30 FLJ00133 protein
NM_015367 MIL1 10.26 BCL2-like 13 (apoptosis facilitator) Caspase activation; induction of apoptosis;
regulation of apoptosis
NM_006337 MCRS1 10.13 Microspherule protein 1
AL136807 SERP1 10.06 Stress-associated endoplasmic
reticulum protein 1
Plasma membrane organization and biogenesis;
protein amino acid glycosylation; response to stress
NM_152374 FLJ38984 10.03 Hypothetical protein FLJ38984
NM_001070 TUBG1;TUBG2 9.89 Tubulin, gamma 1 Microtubule cytoskeleton organization and biogenesis;
microtubule-based movement
NM_018356 FLJ11193 9.76 Hypothetical protein FLJ11193
AL117616 SRI 9.58 Sorcin Heart development; intracellular iron ion storage;
muscle development; regulation of action potential;
regulation of heart rate; regulation of striated
muscle contraction; transport
NM_018985 HCGIV.9 9.50 HLA complex group 4
NM_002950 RPN1 9.50 Ribophorin I Protein amino acid glycosylation
NM_000271 NPC1 9.44 Niemann-Pick disease, type C1 Cholesterol transport; intracellular protein transport
NM_052940 MGC8974 9.36 Hypothetical protein MGC8974
NM_000687 AHCY 9.17 S-adenosylhomocysteine hydrolase One-carbon compound metabolism
NM_005973 PRCC 9.14 Papillary renal cell carcinoma
(translocation-associated)
Cell growth and/or maintenance
NM_017819 FLJ20432 9.14 RNA (guanine-9-) methyltransferase
domain containing 1
NM_002510 GPNMB 9.03 Glycoprotein (transmembrane) nmb Negative regulation of cell proliferation
NM_016129 COPS4 8.91 COP9 constitutive photomorphogenic
homolog subunit 4 (Arabidopsis)
AB032261 SCD 8.85 Stearoyl-coa desaturase (delta-9-desaturase) Fatty acid biosynthesis
AK055297 LSM11 8.82 U7 snrna-associated Sm-like protein
L12711 TKT 8.63 Transketolase (Wernicke-Korsakoff syndrome)
NM_001325 CSTF2 8.61 Cleavage stimulation factor,
3′ pre-RNA, subunit 2, 64 kDa
Mrna cleavage; mrna polyadenylation
U06863 FSTL1 8.60 Follistatin-like 1
NM_006644 HSP105B 8.55 Heat shock 105 kDa/110 kDa protein 1 Protein folding; response to unfolded protein
NM_005494 DNAJB6 8.50 Dnaj (Hsp40) homolog, subfamily B, member 6 Biological_process unknown
NM_001881 CREM 8.48 Camp responsive element modulator Regulation of transcription, DNA-dependent;
signal transduction
NM_005313 GRP58 8.20 Glucose regulated protein, 58 kDa Electron transport; protein-ER retention;
protein-nucleus import; signal transduction
NM_004414 DSCR1 8.19 Down syndrome critical region gene 1 Calcium-mediated signaling; central nervous
system development; circulation; signal transduction
NM_014992 DAAM1 8.05 Dishevelled associated activator
of morphogenesis 1
Actin cytoskeleton organization and biogenesis;
cell organization and biogenesis
NM_006876 B3GNT6 8.02 UDP-glcnac:betagal beta-1,3-
N-acetylglucosaminyltransferase 6
Poly-N-acetyllactosamine biosynthesis
NM_016230 b5&b5R 7.92 NADPH cytochrome B5 oxidoreductase Electron transport; energy pathways;
sensory perception of chemical stimulus
D83778 KIAA0194 7.86 KIAA0194 protein Regulation of transcription, DNA-dependent
NM_014720 SLK 7.85 SNF1 sucrose nonfermenting
like kinase (yeast)
Nucleotide-excision repair;
protein amino acid phosphorylation
NM_005146 SART1 7.82 Squamous cell carcinoma antigen
recognised by T cells
NM_005134 PPP4R1 7.81 Protein phosphatase 4, regulatory subunit 1
NM_004127 GPS1 7.76 G protein pathway suppressor 1 JNK cascade; cell cycle; inactivation of MAPK
AK055491 DNCI2 7.68 Dynein, cytoplasmic, intermediate polypeptide 2 Microtubule-based movement
NM_016229 LOC51700 7.64 Cytochrome b5 reductase b5r.2 Electron transport
NM_000178 GSS 7.59 Glutathione synthetase Amino acid metabolism; glutathione biosynthesis;
neurogenesis; response to oxidative stress
NM_005565 LCP2 7.56 Lymphocyte cytosolic protein 2 (SH2 domain
containing leukocyte protein of 76 kDa)
Immune response; intracellular signaling cascade;
transmembrane receptor protein tyrosine
kinase signaling pathway
NM_014287 PM5 7.41 Hypothetical protein LOC283820 Biological_process unknown
NM_033657 DAP3 7.33 Death associated protein 3 Apoptosis; induction of apoptosis by
extracellular signals
NM_012413 QPCT 7.28 Glutaminyl-peptide cyclotransferase
(glutaminyl cyclase)
Protein modification
NM_031304 MGC4293 7.26 Hypothetical protein MGC4293
NM_013390 TMEM2 7.26 Transmembrane protein 2
NM_012164 FBXW2 7.22 F-box and WD-40 domain protein 2 Ubiquitin cycle
NM_032737 LMNB2 7.22 Lamin B2 Biological_process unknown
NM_000788 DCK 7.19 Deoxycytidine kinase Nucleobase, nucleoside, nucleotide and nucleic
acid metabolism; pyrimidine nucleotide metabolism
NM_003146 SSRP1 7.12 Structure specific recognition protein 1 Regulation of transcription, DNA-dependent
NM_001695 ATP6C 7.08 Atpase, H+ transporting, lysosomal 42 kDa,
V1 subunit C, isoform 1
ATP synthesis coupled proton transport; cell
surface receptor linked signal transduction;
development
NM_018050 FLJ10298 7.02 Hypothetical protein FLJ10298
BC033103 INPP5E 6.99 Peptidase (mitochondrial processing) alpha Proteolysis and peptidolysis
NM_031216 SEC13L 6.99 Sec13-like protein Intracellular protein transport
AB032973 LCHN 6.94 LCHN protein
NM_007002 ADRM1 6.90 Adhesion regulating molecule 1 Cell adhesion
NM_015922 H105E3 6.86 NAD(P) dependent steroid dehydrogenase-like Cholesterol biosynthesis; steroid biosynthesis
NM_003171 SUPV3L1 6.77 Suppressor of var1, 3-like 1 (S. cerevisiae)
NM_004184 WARS 6.75 Tryptophanyl-trna synthetase Negative regulation of cell proliferation; protein biosynthesis; tryptophanyl-trna aminoacylation
NM_005826 HNRPR 6.69 Heterogeneous nuclear ribonucleoprotein R Mrna processing
NM_003915 CPNE1 6.66 Copine I Lipid metabolism; vesicle-mediated transport
NM_032179 FLJ20542 6.66 Hypothetical protein FLJ20542
NM_001315 MAPK14 6.66 Mitogen-activated protein kinase 14 Antimicrobial humoral response (sensu Vertebrata);
cell motility; cell surface receptor linked signal
transduction; chemotaxis; protein amino acid
phosphorylation; protein kinase cascade;
response to stress
NM_018142 FLJ10569 6.61 Hypothetical protein FLJ10569
BC006427 KIAA1279 6.61 Kiaa1279
NM_004749 CPR2 6.53 Transforming growth factor beta regulator 4 G1 phase of mitotic cell cycle; cell cycle arrest;
positive regulation of cell proliferation
NM_005765 ATP6IP2 6.45 Atpase, H+ transporting, lysosomal
accessory protein 2
NM_005499 UBA2 6.45 SUMO-1 activating enzyme subunit 2 Ubiquitin cycle
NM_002767 PRPSAP2 6.43 Phosphoribosyl pyrophosphate
synthetase-associated protein 2
Nucleoside metabolism; nucleotide biosynthesis
NM_003338 UBE2D1 6.28 Ubiquitin-conjugating enzyme E2D 1
(UBC4/5 homolog, yeast)
Ubiquitin cycle; ubiquitin-dependent
protein catabolism
NM_133436 ASNS 6.27 Asparagine synthetase Asparagine biosynthesis; glutamine metabolism
AK057548 LOC154790 6.26 CDNA FLJ32986 fis, clone THYMU1000029
NM_001105 ACVR1 6.15 Activin A receptor, type I Protein amino acid phosphorylation; transmembrane
receptor protein serine/threonine kinase signaling pathway
NM_002444 MSN 6.12 Moesin Cell motility
NM_017982 FLJ10052 6.11 Hypothetical protein FLJ10052
NM_000304 PMP22 6.10 Peripheral myelin protein 22 Mechanosensory behavior; negative regulation of cell
proliferation; perception of sound; peripheral nervous
system development; synaptic transmission
NM_000274 OAT 6.08 Ornithine aminotransferase (gyrate atrophy) Amino acid metabolism; ornithine metabolism;
visual perception
NM_002835 PTPN12 6.02 Protein tyrosine phosphatase,
non-receptor type 12
Protein amino acid dephosphorylation
NM_022758 FLJ22195 6.00 Chromosome 6 open reading frame 106
NM_015646 RAP1B 5.98 RAP1B, member of RAS oncogene family Small gtpase mediated signal transduction
NM_003300 TRAF3 5.97 TNF receptor-associated factor 3 Apoptosis; induction of apoptosis; signal transduction
NM_017613 DONSON 5.95 Downstream neighbor of SON Biological_process unknown
BC023525 C6orf69 5.92 Chromosome 6 open reading frame 69
AF155110 NY-REN-45 5.90 Similar to potassium channel proteins;
Homo sapiens NY-REN-45 antigen mrna,
complete cds.
NM_032333 MGC4248 5.84 Hypothetical protein MGC4248
NM_005745 BCAP31 5.80 B-cell receptor-associated protein 31 Apoptosis; immune response; intracellular
protein transport
AK022632 UAP1L1 5.70 UDP-N-acteylglucosamine
pyrophosphorylase 1-like 1
Metabolism
NM_002532 NUP88 5.69 Nucleoporin 88 kDa Transport
NM_007158 D1S155E 5.66 NRAS-related gene Male gonad development; regulation of transcription,
DNA-dependent
NM_004317 ASNA1 5.59 Arsa arsenite transporter, ATP-binding,
homolog 1 (bacterial)
Anion transport; response to arsenate
NM_001877 CR2 5.59 Complement component
(3d/Epstein Barr virus) receptor 2
Complement activation, classical pathway;
immune response
AL834171 MGC16733 5.58 Hypothetical gene MGC16733
similar to CG12113
NM_004060 CCNG1 5.56 Cyclin G1 Cell cycle; cytokinesis; mitosis; regulation of cyclin
dependent protein kinase activity
NM_014847 KIAA0144 5.54 NICE-4 protein
NM_003600 STK15;STK6 5.51 Serine/threonine kinase 6 Cell cycle; mitosis; protein amino acid phosphorylation
NM_006559 KHDRBS1 5.46 KH domain containing, RNA binding,
signal transduction associated 1
G1/S transition of mitotic cell cycle;
RAS protein signal transduction; cell cycle arrest;
cell proliferation; mrna processing
NM_012113 CA14 5.45 Carbonic anhydrase XIV One-carbon compound metabolism
NM_005805 POH1 5.21 Synonyms: PAD1, POH1, rpn11; go_component:
26S proteasome [goid 0005837] [evidence TAS]
[pmid 9374539]; go_component: cytosol
[goid 0005829] [evidence IEA]; go_component:
proteasome complex (sensu Eukarya)
[goid 0000502] [evidence TAS]; go_process:
ubiquitin-dependent protein catabolism
[goid 0006511] [evidence TAS] [pmid 9374539];
Homo sapiens proteasome (prosome, macropain)
26S subunit, non-atpase, 14 (PSMD14), mrna.
Ubiquitin-dependent protein catabolism
NM_018312 C11orf23 5.19 Chromosome 11 open reading frame 23
AF222345 SUFU 5.19 Suppressor of fused homolog (Drosophila) Regulation of transcription, DNA-dependent
NM_014321 ORC6L 5.16 Origin recognition complex, subunit
6 homolog-like (yeast)
DNA replication
NM_004600 SSA2 5.16 Sjogren syndrome antigen A2 (60 kDa,
ribonucleoprotein autoantigen SS-A/Ro)
Transcription from Pol III promoter
NM_006400 DCTN2 5.15 Dynactin 2 (p50) Cell proliferation; microtubule-based process; mitosis
AL832599 STARD4; 5.12 START domain containing 4, sterol regulated Lipid transport; steroid biosynthesis
AB033023 FLJ10201 5.11 Hypothetical protein FLJ10201 Regulation of transcription, DNA-dependent
NM_021824 NIF3L1 5.10 NIF3 NGG1 interacting factor 3-like 1 (S. Pombe)
NM_003896 SIAT9 5.07 Sialyltransferase 9 (CMP-neuac:lactosylceramide
alpha-2,3-sialyltransferase; GM3 synthase)
Ganglioside biosynthesis; protein amino
acid glycosylation
NM_004568 SERPINB6 5.06 Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 6
NM_020151 STARD7 5.02 START domain containing 7
NM_004368 CNN2 5.00 Calponin 2 Cytoskeleton organization and biogenesis;
smooth muscle contraction
AJ251973 NAV1; POMFIL3;
FLJ12560; FLJ14203;
KIAA1151;
MGC14961;
steerin-1
5.00 Homo sapiens partial steerin-1 gene. DNA methylation
NM_000819 GART 4.97 Phosphoribosylglycinamide formyltransferase,
phosphoribosylglycinamide synthetase,
phosphoribosylaminoimidazole synthetase
De novo’ IMP biosynthesis; purine base biosynthesis;
purine nucleotide biosynthesis
U03851 CAPZA2 4.96 Capping protein (actin filament)
muscle Z-line, alpha 2
Actin cytoskeleton organization and biogenesis;
cell motility; protein complex assembly
U03851 CAPZA2 4.75 Capping protein (actin filament)
muscle Z-line, alpha 2
Actin cytoskeleton organization and biogenesis;
cell motility; protein complex assembly
NM_021129 PP 4.69 Pyrophosphatase (inorganic) Metabolism; phosphate metabolism
NM_007217 PDCD10 4.68 Programmed cell death 10
AK055660 MTPN 4.56 Myotrophin
Down-regulated
NM_000800 FGF1 −100.00 Fibroblast growth factor 1 (acidic) Angiogenesis; cell proliferation; cell-cell signaling;
morphogenesis; regulation of cell cycle;
signal transduction
NM_020411 GAGED2 −100.00 G antigen, family D, 2
AL120032 GABRB3 −100.00 Gamma-aminobutyric acid (GABA)
A receptor, beta 3
NM_024736 FLJ12150 −100.00 Hypothetical protein FLJ12150
NM_006158 NEFL −100.00 Neurofilament, light polypeptide 68 kDa
BC008915 SERPINA3 −68.97 Serine (or cysteine) proteinase inhibitor,
clade A (alpha-1 antiproteinase, antitrypsin),
member 3
NM_025181 FLJ22004 −59.17 Solute carrier family 35, member F5
NM_002050 GATA2 −57.47 Synonyms: NFE1B, MGC2306; GATA-binding
protein 2; go_component: nucleus [goid 0005634]
[evidence TAS] [pmid 1370462]; go_function:
transcription activating factor [goid 0003710]
[evidence E] [pmid 1370462]; go_function:
transcription factor activity [goid 0003700]
[evidence TAS] [pmid 8078582]; go_function:
translation regulator activity [goid 0045182]
[evidence IEA]; go_process: cell growth
and/or maintenance [goid 0008151] [evidence TAS]
[pmid 8078582]; go_process: transcription from
Pol II promoter [goid 0006366] [evidence TAS]
[pmid 1370462]; go_process: regulation of
transcription, DNA-dependent [goid 0006355]
[evidence IEA]; Homo sapiens GATA
binding protein 2 (GATA2), mrna.
NM_002922 RGS1 −44.05 Regulator of G-protein signalling 1 B-cell activation; G-protein signaling, adenylate
cyclase inhibiting pathway; immune response;
signal transduction
NM_004335 BST2 −27.40 Bone marrow stromal cell antigen 2 Cell proliferation; cell-cell signaling; development;
humoral immune response; positive regulation of
I-kappab kinase/NF-kappab cascade
NM_007283 MGLL −26.81 Monoglyceride lipase Aromatic compound metabolism;
inflammatory response; lipid metabolism
NM_021992 TMSNB −25.00 Thymosin, beta, identified in neuroblastoma cells Cytoskeleton organization and biogenesis
AL137259 DKFZp434D0513 −23.98 Hydrocephalus inducing
NM_024600 FLJ20898 −21.32 Hypothetical protein FLJ20898
NM_152773 MGC33212 −16.67 Hypothetical protein MGC33212
NM_018476 BEX1 −16.50 Brain expressed, X-linked 1
NM_001187 BAGE −16.34 B melanoma antigen
NM_001266 CES1 −15.97 Carboxylesterase 1 (monocyte/
macrophage serine esterase 1)
Metabolism; response to toxin
NM_000170 GLDC −15.75 Glycine dehydrogenase (decarboxylating;
glycine decarboxylase, glycine
cleavage system protein P)
Glycine catabolism
NM_139177 C17orf26 −14.95 Solute carrier family 39
(metal ion transporter), member 11
Metal ion transport
NM_001869 CPA2 −14.18 Carboxypeptidase A2 (pancreatic) Proteolysis and peptidolysis; vacuolar
protein catabolism
U83115 AIM1 −12.77 Absent in melanoma 1
NM_001719 BMP7 −12.32 Bone morphogenetic protein 7
(osteogenic protein 1)
Growth; skeletal development
NM_005574 LMO2 −12.02 LIM domain only 2 (rhombotin-like 1) Cell growth and/or maintenance; development
NM_004609 TCF15 −11.89 Transcription factor 15 (basic helix-loop-helix) Development; mesoderm development; regulation
of transcription from Pol II promoter
NM_003227 TFR2 −11.82 Transferrin receptor 2 Iron ion transport; proteolysis and peptidolysis
AF288741 OSBP2 −11.81 Oxysterol binding protein 2 Lipid transport; steroid metabolism
NM_016429 COPZ2 −11.52 Coatomer protein complex, subunit zeta 2 Intracellular protein transport
NM_002250 KCNN4 −11.27 Potassium intermediate/small conductance
calcium-activated channel,
subfamily N, member 4
Defense response; ion transport;
potassium ion transport
BC015794 FLJ10097 −10.47 Hypothetical protein FLJ10097
NM_005712 HHLA1 −9.90 HERV-H LTR-associating 1
NM_005978 S100A2 −9.90 S100 calcium binding protein A2 Biological_process unknown
NM_002928 RGS16 −9.80 Regulator of G-protein signalling 16 Regulation of G-protein coupled receptor
protein signaling pathway; signal transduction;
visual perception
NM_032638 MGC2306 −9.35 GATA binding protein 2 Cell growth and/or maintenance; regulation of
transcription, DNA-dependent; transcription from
Pol II promoter
BF344649 MGC8685 −8.85 Tubulin, beta polypeptide paralog
NM_004078 CSRP1 −8.47 Cysteine and glycine-rich protein 1
NM_003733 OASL −8.40 2′-5′-oligoadenylate synthetase-like Immune response
NM_006417 MTAP44 −8.40 Interferon-induced protein 44 Response to virus
 NM006169 NNMT −8.20 Nicotinamide N-methyltransferase
AL834409 DKFZp547J144 −8.20 Reticulon 4 receptor-like 1
AF399547 OR1N1; OR1N3;
OR1-26
−7.52 Contains transmembrane regions 2-7;
Homo sapiens clone OR1N3 olfactory
receptor gene, partial cds.
G-protein coupled receptor protein signaling pathway;
perception of smell
NM_001175 ARHGDIB −7.25 Rho GDP dissociation inhibitor (GDI) beta Rho protein signal transduction; actin cytoskeleton
organization and biogenesis; development;
immune response; negative regulation of cell adhesion
AK074703 LOC89944 −7.09 Hypothetical protein BC008326 Carbohydrate metabolism
NM_004924 ACTN4 −7.04 Actinin, alpha 4 Cell motility
AI123815 FLJ21963 −7.04 FLJ21963 protein
NM_032261 DKFZp434N0650 −6.90 Chromosome 21 open reading frame 56
NM_006993 NPM3 −6.85 Nucleophosmin/nucleoplasmin, 3 Protein folding
BC009033 LOC253982 −6.80 Hypothetical protein LOC253982 Peptidyl-amino acid modification
NM_005794 HEP27 −6.76 Dehydrogenase/reductase
(SDR family) member 2
Metabolism
NM_012219 MRAS −6.71 Muscle RAS oncogene homolog RAS protein signal transduction; actin cytoskeleton
organization and biogenesis; development;
muscle development
AB067508 KIAA1921 −6.58 Start codon is not identified.; Homo sapiens
mrna for KIAA1921 protein, partial cds.
NM_004711 SYNGR1 −6.49 Synaptogyrin 1
NM_020169 LXN −6.29 Latexin protein
NM_018170 FLJ10656 −6.21 Hypothetical protein FLJ10656
NM_004107 FCGRT −6.13 Fc fragment of igg, receptor, transporter, alpha Immune response; pregnancy
NM_018265 FLJ10901 −6.10 Hypothetical protein FLJ10901
NM_006302 GCS1 −6.06 Glucosidase I N-linked glycosylation; carbohydrate metabolism;
oligosaccharide metabolism
NM_003633 ENC1 −5.85 Ectodermal-neural cortex (with BTB-like domain) Development; neurogenesis
NM_004583 RAB5C −5.81 RAB5C, member RAS oncogene family Intracellular protein transport; small gtpase
mediated signal transduction
AK074859 LOC147808 −5.71 Similar to zinc finger protein
BE615983 STUB1 −5.71 STIP1 homology and U-Box containing protein 1
NM_018022 FLJ10199 −5.59 Hypothetical protein FLJ10199
NM_024710 FLJ23469 −5.49 Hypothetical protein FLJ23469 Metabolism
NM_016202 LOC51157 −5.46 Zinc finger protein 580 Regulation of transcription, DNA-dependent
AJ011713 TNNT1 −5.38 Homo sapiens TNNT1 gene, exons 12-14. Muscle development; regulation of muscle contraction
NM_003283 TNNT1 −5.35 Troponin T1, skeletal, slow Muscle development; regulation of muscle contraction
NM_032488 LOC84518 −5.15 Protein related with psoriasis
AK055959 TOM1L2 −5.08 Target of myb1-like 2 (chicken) Intra-Golgi transport; intracellular protein transport
NM_001060 TBXA2R −4.98 Thromboxane A2 receptor G-protein coupled receptor protein signaling pathway;
muscle contraction; respiratory gaseous exchange
NM_002514 NOV −4.88 Nephroblastoma overexpressed gene Regulation of cell growth
NM_000117 EMD −4.83 Emerin (Emery-Dreifuss muscular dystrophy) Muscle contraction; muscle development
NM_007286 KIAA1029 −4.72 Synaptopodin
NM_018956 C9orf9 −4.67 Chromosome 9 open reading frame 9
NM_032603 LOXL3 −4.67 Lysyl oxidase-like 3 Biological_process unknown
NM_015681 B9 −4.65 B9 protein
NM_014849 SV2 −4.63 Synaptic vesicle glycoprotein 2A Transport

Table I. Overlapping differentially regulated genes, FEMX-I and FEMX-V vs. the derived tumor xenografts.

GenBank ID Common
name
Xenograft
fold
change
Cell line
fold
change
Description
Up-regulated
NM_003752 EIF3S8 51.96 53.86 Eukaryotic translation initiation factor 3, subunit 8, 110 kDa
NM_000181 GUSB 47.20 11.92 Glucuronidase, beta
NM_006111 ACAA2 40.84 11.94 Acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase)
NM_001416 EIF4A1 32.61 5.60 Eukaryotic translation initiation factor 4A, isoform 1
AB014540 KIAA0640 31.32 4.98 SWAP-70 protein
NM_000967 RPL3 31.15 6.48 Ribosomal protein L3
NM_004559 NSEP1 30.48 5.75 Nuclease sensitive element binding protein 1
NM_003405 YWHAH 29.89 15.51 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, eta polypeptide
NM_002136 HNRPA1 25.64 12.66 Heterogeneous nuclear ribonucleoprotein A1
NM_001402 EEF1A1 23.53 23.74 Eukaryotic translation elongation factor 1 alpha 1
NM_022818 MAP1LC3B 23.26 4.77 Microtubule-associated protein 1 light chain 3 beta
NM_024057 MGC5585 22.39 4.94 Nucleoporin Nup37
NM_017812 FLJ20420 20.99 5.42 Coiled-coil-helix-coiled-coil-helix domain containing 3
NM_000291 PGK1 19.45 16.23 Phosphoglycerate kinase 1
NM_003418 ZNF9 19.43 5.46 Zinc finger protein 9 (a cellular retroviral nucleic acid binding protein)
NM_001316 CSE1L 16.88 7.74 CSE1 chromosome segregation 1-like (yeast)
NM_020216 RNPEP 16.60 6.94 Arginyl aminopeptidase (aminopeptidase B)
BC008861 ATP6D 16.24 4.77 Atpase, H+ transporting, lysosomal 38 kDa, V0 subunit d isoform 1
NM_000183 HADHB 15.98 6.03 Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A
thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit
NM_001154 ANXA5 15.51 8.00 Annexin A5
AL137681 EIF4A2 14.67 10.06 Eukaryotic initiation factor 4AII, unspliced; Homo sapiens mrna;
cdna dkfzp434m0326 (from clone dkfzp434m0326); partial cds.
BC021714 PPFIBP2 14.47 6.97 PTPRF interacting protein, binding protein 2 (liprin beta 2)
NM_014038 HSPC028 14.44 4.62 Basic leucine zipper and W2 domains 2
NM_006070 TFG 14.43 10.61 TRK-fused gene
NM_001762 CCT6A 13.55 11.33 Chaperonin containing TCP1, subunit 6A (zeta 1)
NM_017858 FLJ20516 13.51 5.09 Timeless-interacting protein
NM_004595 SMS 13.16 11.30 Spermine synthase
NM_030810 MGC3178 12.86 4.93 Thioredoxin domain containing 5
AF134802 CFL2 12.40 5.21 Cofilin 2 (muscle)
NM_000182 HADHA 12.38 6.62 Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A
thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit
NM_016359 ANKT 12.36 11.72 Nucleolar and spindle associated protein 1
NM_003142 SSB 11.98 5.77 Sjogren syndrome antigen B (autoantigen La)
NM_014309 RBM9 11.73 9.41 RNA binding motif protein 9
NM_002847 PTPRN2 11.72 6.16 Protein tyrosine phosphatase, receptor type, N polypeptide 2
NM_033317 ZD52F10 11.50 6.69 Hypothetical gene ZD52F10
NM_006743 RBM3 10.81 5.46 RNA binding motif protein 3
NM_015679 CLONE24922 10.55 6.87 Trub pseudouridine (psi) synthase homolog 2 (E. Coli)
NM_003819 PABPC4 9.93 6.50 Poly(A) binding protein, cytoplasmic 4 (inducible form)
NM_001634 AMD1 9.77 5.63 Adenosylmethionine decarboxylase 1
NM_006904 PRKDC 9.51 5.94 Protein kinase, DNA-activated, catalytic polypeptide
NM_022874 SMN1;SMN2 9.44 4.57 Survival of motor neuron 1, telomeric
NM_014062 ART-4 9.40 9.49 Likely ortholog of mouse nin one binding protein
NM_018472 HT011 9.38 5.65 Uncharacterized hypothalamus protein HT011
NM_022337 RAB38 9.19 5.37 RAB38, member RAS oncogene family
NM_012470 TRN-SR 9.06 4.52 Transportin 3
NM_014713 LAPTM4A 8.91 4.85 Lysosomal-associated protein transmembrane 4 alpha
AB037716 KIAA1295;FLJ20831 8.87 5.63 KIAA1295 protein
NM_018206 VPS35 8.83 11.36 Vacuolar protein sorting 35 (yeast)
NM_004125 GNG10 8.76 5.07 Guanine nucleotide binding protein (G protein), gamma 10
NM_006017 PROML1 8.73 9.62 Prominin 1
NM_021105 PLSCR1 8.41 9.49 Phospholipid scramblase 1
NM_031844 HNRPU 8.14 7.20 Heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
NM_002080 GOT2 8.10 25.65 Glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2)
NM_016308 UMP-CMPK 7.68 5.82 UMP-CMP kinase
NM_000520 HEXA 7.29 7.95 Hexosaminidase A (alpha polypeptide)
NM_004046 ATP5A1 7.14 19.12 ATP synthase, H+ transporting, mitochondrial F1 complex,
alpha subunit, isoform 1, cardiac muscle
NM_004868 GPSN2 6.98 5.79 Glycoprotein, synaptic 2
NM_001418 EIF4G2 6.82 24.72 Eukaryotic translation initiation factor 4 gamma, 2
NM_016397 TH1L 6.77 5.82 TH1-like (Drosophila)
AK098818 FLJ25952 6.75 15.21 Hypothetical protein FLJ25952
NM_005704 PTPRU 6.53 14.41 Protein tyrosine phosphatase, receptor type, U
L29065 6.51 5.78 Human DNA-binding protein A gene, exon 2.
NM_024666 FLJ11506 6.46 11.13 Hypothetical protein FLJ11506
NM_001881 CREM 6.44 8.66 Camp responsive element modulator
NM_005348 HSPCA 6.19 18.43 Heat shock 90 kDa protein 1, alpha
AB037723 ODZ4 6.15 6.52 Odd Oz/ten-m homolog 4
NM_022145 FKSG14 6.00 6.91 Leucine zipper protein FKSG14
NM_002079 GOT1 5.96 7.19 Glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1)
NM_019006 AWP1 5.87 8.21 Protein associated with PRK1
NM_024306 FAAH 5.86 12.89 Fatty acid 2-hydroxylase
NM_001908 CTSB 5.46 4.93 Cathepsin B
Down-regulated
NM_017863 FLJ20527 −100.00 −46.08 Hypothetical protein FLJ20527
AB011538 SLIT3 −99.01 −7.75 Slit homolog 3 (Drosophila)
NM_004106 FCER1G −90.91 −75.19 Fc fragment of ige, high affinity I, receptor for; gamma polypeptide
NM_003592 CUL1 −71.43 10.92 Cullin 1
NM_016608 ALEX1 −48.54 −38.91 ALEX1 protein
NM_002961 S100A4 −45.25 −6.06 S100 calcium binding protein A4 (calcium protein, calvasculin,
metastasin, murine placental homolog)
NM_033292 CASP1;COP −28.25 −100.00 Caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase)
NM_017590 RoXaN −27.32 −9.09 Ubiquitous tetratricopeptide containing protein roxan
NM_014909 KIAA1036 −25.45 −20.53 Kiaa1036
X07109 PRKCB1 −24.88 −7.09 Protein kinase C, beta 1
BC011739 APOBEC3C −23.09 −19.05 Apolipoprotein B mrna editing enzyme, catalytic polypeptide-like 3C
NM_001803 CDW52 −20.96 −9.09 CDW52 antigen (CAMPATH-1 antigen)
NM_001778 CD48 −17.70 −99.01 CD48 antigen (B-cell membrane protein)
NM_000237 LPL −16.29 −10.38 Lipoprotein lipase
NM_018659 C17 −14.79 −45.25 Cytokine-like protein C17
AK025833 CD33L3 −11.09 −25.13 CD33 antigen-like 3
NM_018058 CRTAC1 −10.99 −33.44 Cartilage acidic protein 1
NM_015364 MD-2 −10.93 −10.67 Lymphocyte antigen 96
D10537 MPZ −10.41 −47.62 Myelin protein zero (Charcot-Marie-Tooth neuropathy 1B)
AL390147 DKFZp547D065 −10.07 −86.21 Family with sequence similarity 20, member C
AF401235 SLC29A2 −9.62 −15.48 Solute carrier family 29 (nucleoside transporters), member 2
BC015510 RGS1 −8.85 −34.13 Regulator of G-protein signalling 1
NM_012155 EML2 −8.13 5.77 Echinoderm microtubule associated protein like 2
AK026966 AK3 −7.81 −11.93 Adenylate kinase 3
NM_030801 MAGE-E1 −7.63 −20.88 Melanoma antigen, family D, 4
NM_022082 C20orf59 −7.58 −7.81 Chromosome 20 open reading frame 59
NM_000483 APOC2 −6.94 −26.74 Apolipoprotein C-II
NM_012253 TKTL1 −5.95 −17.01 Transketolase-like 1
NM_001553 IGFBP7 −5.62 −17.79 Insulin-like growth factor binding protein 7
NM_004369 COL6A3 −5.32 −5.38 Collagen, type VI, alpha 3

Table III. Unique differentially regulated genes comparison between FEMX-I and FEMX-V tumor xenografts.

GenBank ID Common
name
Fold
change
Description Function
Up-regulated
NM_004214 FIBP 507.00 Fibroblast growth factor (acidic)
intracellular binding protein
Fibroblast growth factor receptor signaling pathway
NM_000165 GJA1 439.00 Gap junction protein, alpha 1,
43 kDa (connexin 43)
Cell-cell signaling; heart development; muscle
contraction; perception of sound; positive regulation
of I-kappab kinase/NF-kappab cascade; transport
NM_014640 KIAA0173 237.00 Tubulin tyrosine ligase-like family, member 4 Protein modification
NM_021979 HSPA2 229.00 Heat shock 70 kDa protein 2 Male meiosis; spermatid development
AF300796 CSE-C 164.00 Cytosolic sialic acid 9-O-acetylesterase homolog
NM_012311 KIN 96.38 KIN, antigenic determinant of reca
protein homolog (mouse)
NM_000188 HK1 93.04 Hexokinase 1 Glycolysis
NM_016113 TRPV2 69.01 Transient receptor potential cation channel,
subfamily V, member 2
Cation transport; sensory perception
NM_015610 DKFZP434J154 62.59 DKFZP434J154 protein
NM_001099 ACPP 62.51 Acid phosphatase, prostate Regulation of cell cycle
NM_007017 SOX30 60.01 SRY (sex determining region Y)-box 30 Regulation of transcription from Pol II promoter;
spermatogenesis
NM_000167 GK 51.31 Glycerol kinase Carbohydrate metabolism;
glycerol-3-phosphate metabolism
NM_003750 EIF3S10 49.46 Eukaryotic translation initiation factor 3,
subunit 10 theta, 150/170 kDa
Protein biosynthesis; regulation of
translational initiation
NM_018702 ADAR3 48.50 Adenosine deaminase, RNA-specific, B2
(RED2 homolog rat)
Mrna editing; mrna processing
NM_000308 PPGB 48.29 Protective protein for beta-galactosidase
(galactosialidosis)
Intracellular protein transport; proteolysis
and peptidolysis
NM_014065 HT001 44.69 HT001 protein
NM_003367 USF2 43.19 Upstream transcription factor 2, c-fos interacting Regulation of transcription, DNA-dependent
AK024450 ARHT2 43.05 Ras homolog gene family, member T2 Small gtpase mediated signal transduction
NM_000375 UROS 41.01 Uroporphyrinogen III synthase
(congenital erythropoietic porphyria)
Heme biosynthesis; uroporphyrinogen III biosynthesis
NM_024689 FLJ14103 37.77 Hypothetical protein FLJ14103
NM_005412 SHMT2 36.17 Serine hydroxymethyltransferase
2 (mitochondrial)
L-serine metabolism; glycine metabolism;
one-carbon compound metabolism
NM_004862 PIG7 36.14 Lipopolysaccharide-induced TNF factor Positive regulation of I-kappab kinase/NF-kappab
cascade; regulation of transcription
from Pol II promoter
BC002980 SCRN2 34.47 Secernin 2 Proteolysis and peptidolysis
NM_018410 DKFZp762E1312 33.04 Hypothetical protein dkfzp762e1312
NM_032801 JAM3 32.75 Junctional adhesion molecule 3
NM_003681 PDXK 32.05 Pyridoxal (pyridoxine, vitamin B6) kinase
NM_022449 RAB17 30.90 RAB17, member RAS oncogene family Intracellular protein transport; small gtpase
mediated signal transduction
NM_002046 GAPD 29.98 Glyceraldehyde-3-phosphate dehydrogenase Glucose metabolism; glycolysis
NM_003900 SQSTM1 28.30 Sequestosome 1 Endosome transport; intracellular signaling cascade;
positive regulation of transcription from
Pol II promoter; protein localization; regulation
of I-kappab kinase/NF-kappab cascade;
response to stress
L09674 SLC2A2; GLUT2 26.57 Human glucose transporter 2
(GLUT2) gene, exon 1.
Carbohydrate metabolism; carbohydrate transport;
glucose transport
NM_145792 MGST1 26.39 Microsomal glutathione S-transferase 1
AK054993 RAC1 26.38 Ras-related C3 botulinum toxin substrate 1
(rho family, small GTP binding protein Rac1)
Cell adhesion; cell motility; inflammatory response;
morphogenesis; small gtpase mediated
signal transduction
NM_002300 LDHB 26.03 Lactate dehydrogenase B Glycolysis; tricarboxylic acid cycle
intermediate metabolism
NM_002629 PGAM1 25.26 Phosphoglycerate mutase 1 (brain) Glycolysis; metabolism
NM_002077 GOLGA1 24.72 Golgi autoantigen, golgin subfamily a, 1
NM_015640 PAI-RBP1 24.27 PAI-1 mrna-binding protein
NM_005418 ST5 24.19 Suppression of tumorigenicity 5
NM_005968 HNRPM 23.87 Heterogeneous nuclear ribonucleoprotein M
NM_001968 EIF4E 23.69 Eukaryotic translation initiation factor 4E Regulation of protein biosynthesis;
regulation of translation; translational initiation
NM_001496 GFRA3 23.51 GDNF family receptor alpha 3 Peripheral nervous system development;
signal transduction
NM_001679 ATP1B3 23.42 Atpase, Na+/K+ transporting, beta 3 polypeptide Potassium ion transport; sodium ion transport
NM_000041 APOE 23.30 Apolipoprotein E Cholesterol homeostasis; circulation; cytoskeleton
organization and biogenesis; induction of apoptosis;
intracellular transport; learning and/or memory;
lipid transport; lipoprotein metabolism; regulation
of axon extension; regulation of neuronal
synaptic plasticity; response to reactive oxygen species;
synaptic transmission, cholinergic
AA933967 SPRY3 23.30 Sprouty homolog 3 (Drosophila)
NM_005507 CFL1 22.71 Cofilin 1 (non-muscle) Rho protein signal transduction; actin cytoskeleton
organization and biogenesis
NM_000403 GALE 22.55 Galactose-4-epimerase, UDP- Carbohydrate metabolism; galactose metabolism;
nucleotide-sugar metabolism
NM_020162 DDX33 22.48 DEAH (Asp-Glu-Ala-His) box polypeptide 33
NM_006170 NOL1 22.35 HOM-TES-103 tumor antigen-like Positive regulation of cell proliferation;
regulation of cell cycle
NM_004570 PIK3C2G 22.18 Phosphoinositide-3-kinase, class 2,
gamma polypeptide
Intracellular signaling cascade
NM_018223 CHFR 21.83 Checkpoint with forkhead and ring finger domains
AK057343 ZNF131 21.32 Zinc finger protein 131 (clone phz-10) Regulation of transcription, DNA-dependent
NM_001469 G22P1 21.30 Thyroid autoantigen 70 kDa (Ku antigen) DNA ligation; double-strand break repair via
nonhomologous end-joining
NM_016372 TPRA40 20.85 Seven transmembrane domain orphan receptor Aging; lipid metabolism
NM_006098 GNB2L1 20.34 Guanine nucleotide binding protein
(G protein), beta polypeptide 2-like 1
Protein kinase C activation; signal transduction
NM_005216 DDOST 20.27 Dolichyl-diphosphooligosaccharide-
protein glycosyltransferase
N-linked glycosylation via asparagine
AB002376 KIAA0378 19.92 CAZ-associated structural protein
NM_006821 ZAP128 19.79 Peroxisomal long-chain acyl-coa thioesterase Acyl-coa metabolism; lipid metabolism
NM_000874 IFNAR2 19.42 Interferon (alpha, beta and omega) receptor 2 JAK-STAT cascade; cell surface receptor linked signal
transduction; response to virus
AB011173 KIAA0601 19.08 Amine oxidase (flavin containing) domain 2 Electron transport
NM_002087 GRN 18.86 Granulin Cell proliferation; cell-cell signaling; positive regulation
of cell proliferation; signal transduction
NM_006088 TUBB2 18.38 Tubulin, beta, 2 Microtubule polymerization; microtubule-based
movement
NM_016180 MATP 18.35 Membrane associated transporter Melanin biosynthesis from tyrosine; visual perception
NM_000447 PSEN2 18.26 Presenilin 2 (Alzheimer disease 4) Apoptotic program; chromosome organization and
biogenesis (sensu Eukarya); chromosome segregation;
intracellular signaling cascade
NM_005083 U2AF1RS1;
U2AF1RS2
18.21 Signal recognition particle 19 kDa Biological_process unknown
NM_002455 MTX1 18.13 Metaxin 1 Protein transport
NM_006791 MRG15 17.90 Mortality factor 4 like 1 Chromatin assembly/disassembly; regulation of cell growth
NM_015966 SDBCAG84 17.43 Serologically defined breast cancer antigen 84
NM_005720 ARPC1B 17.41 Actin related protein 2/3 complex,
subunit 1B, 41 kDa
Cell motility
BC014110 LOC132241 17.41 Hypothetical protein LOC132241 Protein biosynthesis
NM_004592 SFRS8 17.18 Splicing factor, arginine/serine-rich 8
(suppressor-of-white-apricot homolog,
Drosophila)
Mrna splice site selection; nuclear mrna splicing,
via spliceosome; regulation of transcription,
DNA-dependent
NM_004279 PMPCB 17.02 Peptidase (mitochondrial processing) beta Proteolysis and peptidolysis
NM_000143 FH 16.98 Fumarate hydratase Fumarate metabolism; negative regulation of cell cycle;
tricarboxylic acid cycle
NM_002265 KPNB1 16.97 Karyopherin (importin) beta 1 NLS-bearing substrate-nucleus import; intracellular
protein transport; protein-nucleus import, docking;
protein-nucleus import, translocation
NM_004147 DRG1 16.90 Developmentally regulated GTP binding protein 1 Development; transcription
AJ223353 H2BFB 16.81 Histone 1, h2bd Chromosome organization and biogenesis
(sensu Eukarya); nucleosome assembly
NM_005956 MTHFD1 16.09 Methylenetetrahydrofolate dehydrogenase
(NADP+ dependent), methenyltetrahydrofolate
cyclohydrolase, formyltetrahydrofolate synthetase
Amino acid biosynthesis; folic acid and
derivative biosynthesis; histidine biosynthesis;
methionine biosynthesis; one-carbon compound
metabolism; purine nucleotide biosynthesis
AL049365 MGC50853 16.03 MRNA; cdna dkfzp586a0618
(from clone dkfzp586a0618)
AB007856 FEM1B 15.97 Fem-1 homolog b (C. elegans) Induction of apoptosis
NM_000701 ATP1A1 15.93 Atpase, Na+/K+ transporting,
alpha 1 polypeptide
sodium ion transport; sperm motility
ATP hydrolysis coupled proton transport; hydrogen
ion homeostasis; metabolism; potassium ion transport;
NM_004988 MAGEA1 15.84 Melanoma antigen, family A, 1
(directs expression of antigen MZ2-E)
BC030618 LOC196463 15.75 Hypothetical protein LOC196463
NM_004637 RAB7 15.61 RAB7, member RAS oncogene family Endocytosis; intracellular protein transport;
small gtpase mediated signal transduction
NM_001122 ADFP 15.54 Adipose differentiation-related protein
NM_014677 RIMS2 15.28 Regulating synaptic membrane exocytosis 2 Intracellular protein transport
NM_004596 SNRPA 15.23 Small nuclear ribonucleoprotein polypeptide A
AF204171 POP3 15.13 Popeye domain containing 3 Biological_process unknown
NM_016001 LOC51096 14.93 CGI-48 protein
NM_022157 GTR2 14.89 Ras-related GTP binding C RNA splicing; apoptosis; cell growth; cell growth and/or
maintenance; small gtpase mediated signal
transduction; transcription
AK057545 PLDN 14.87 Pallidin homolog (mouse) Synaptic vesicle docking
NM_000248 MITF 14.71 Microphthalmia-associated transcription factor Development; melanocyte differentiation; perception
of sound; regulation of transcription, DNA-dependent
NM_005273 GNB2 14.66 Guanine nucleotide binding protein (G protein),
beta polypeptide 2
G-protein coupled receptor protein signaling pathway;
signal transduction
NM_032558 FLJ14753 14.59 Hypothetical protein FLJ14753 Tetracycline transport
NM_012067 AKR7A3 14.46 Aldo-keto reductase family 7, member A3
(aflatoxin aldehyde reductase)
Aldehyde metabolism
NM_005637 SS18 14.28 Synovial sarcoma translocation, chromosome 18 Cell growth and/or maintenance
NM_016535 HSPC189 14.07 Zinc finger protein 581 Regulation of transcription, DNA-dependent
NM_020357 PCNP 14.05 PEST-containing nuclear protein
NM_005466 MED6 14.01 Mediator of RNA polymerase II transcription,
subunit 6 homolog (yeast)
Regulation of transcription, DNA-dependent
AB037843 KIAA1422 13.89 Potassium channel, subfamily T, member 1 Ion transport; potassium ion transport
NM_004159 PSMB8 13.81 Proteasome (prosome, macropain) subunit,
beta type, 8 (large multifunctional protease 7)
Immune response; proteolysis and peptidolysis;
ubiquitin-dependent protein catabolism
X53305 STMN1 13.76 Stathmin 1/oncoprotein 18 Cell growth and/or maintenance; intracellular
signaling cascade
NM_003831 SUDD 13.72 RIO kinase 3 (yeast) Chromosome segregation
NM_002817 PSMD13 13.67 Proteasome (prosome, macropain)
26S subunit, non-atpase, 13
BC007195 NCK2 13.64 NCK adaptor protein 2 T-cell activation; intracellular signaling cascade;
negative regulation of cell proliferation; positive
regulation of T-cell proliferation; positive regulation of
actin filament polymerization; regulation of epidermal
growth factor receptor activity; signal complex formation
BC019236 HLA-A 13.47 Major histocompatibility complex, class I, A Antigen presentation, endogenous antigen; antigen
processing, endogenous antigen via MHC class I;
immune response
NM_024663 NPEPL1 13.45 Aminopeptidase-like 1 Proteolysis and peptidolysis
NM_003883 HDAC3 13.44 Histone deacetylase 3 Anti-apoptosis; chromatin modification; histone
deacetylation; regulation of cell cycle;
regulation of transcription, DNA-dependent
NM_023016 FLJ21870 13.43 Septin 10
NM_005569 LIMK2 13.21 LIM domain kinase 2 Protein amino acid phosphorylation
NM_002574 PRDX1 13.21 Peroxiredoxin 1 Cell proliferation; skeletal development
NM_002914 RFC2 13.16 Replication factor C (activator 1) 2, 40 kDa DNA replication
NM_004071 CLK1 13.08 CDC-like kinase 1 Cell proliferation; protein amino acid phosphorylation;
regulation of cell cycle
NM_012173 FBXO25 13.01 F-box only protein 25 Ubiquitin cycle
NM_001975 ENO2 12.84 Enolase 2 (gamma, neuronal) Glycolysis
NM_017920 URG4 12.80 Up-regulated gene 4
NM_018380 DDX28 12.69 Hypothetical protein FLJ20399
NM_013379 DPP7 12.66 Dipeptidylpeptidase 7 Proteolysis and peptidolysis
NM_012179 FBXO7 12.66 F-box only protein 7 Ubiquitin-dependent protein catabolism
NM_033133 CNP 12.62 2′,3′-Cyclic nucleotide 3′ phosphodiesterase Cyclic nucleotide catabolism; synaptic transmission
NM_014575 SCHIP1 12.58 Schwannomin interacting protein 1 Biological_process unknown
NM_012079 DGAT1 12.54 Diacylglycerol O-acyltransferase
homolog 1 (mouse)
Fat body development; triacylglycerol metabolism
NM_006397 RNASEHI 12.47 Jun B proto-oncogene DNA replication; RNA catabolism
BC002971 CCT5 12.44 Chaperonin containing TCP1, subunit 5 (epsilon) Protein folding
NM_000018 ACADVL 12.43 Acyl-coenzyme A dehydrogenase, very long chain Electron transport; energy derivation by oxidation
of organic compounds; fatty acid beta-oxidation;
fatty acid metabolism
NM_002266 KPNA2 12.41 Karyopherin alpha 2 (RAG cohort 1, importin
alpha 1)
DNA metabolism; G2 phase of mitotic cell cycle;
M phase specific microtubule process; NLS-bearing
substrate-nucleus import; intracellular protein
transport; regulation of DNA recombination
NM_006913 RNF5 12.41 Ring finger protein 5 Protein ubiquitination
BE737594 RBPSUH 12.39 Recombining binding protein suppressor
of hairless (Drosophila)
NM_006367 CAP 12.38 CAP, adenylate cyclase-associated
protein 1 (yeast)
Adenylate cyclase activation; establishment and/or
maintenance of cell polarity; signal transduction
NM_012111 C14orf3 12.31 AHA1, activator of heat shock 90 kDa protein
atpase homolog 1 (yeast)
Protein folding; response to stress
NM_003299 TRA1 12.28 Tumor rejection antigen (gp96) 1 Protein folding; response to stress
AF154121 SLC13A3 12.14 Solute carrier family 13 (sodium-dependent
dicarboxylate transporter), member 3
Sodium ion transport
NM_006115 PRAME 12.11 Preferentially expressed antigen in melanoma
AK027480 ZNF266; HZF1 12.07 Unnamed protein product; Homo sapiens cdna
FLJ14574 fis, clone NT2RM4000751, moderately
similar to ZINC FINGER PROTEIN 184.
Regulation of transcription, DNA-dependent
NM_006758 U2AF1 11.99 U2(RNU2) small nuclear RNA auxiliary factor 1 RNA splicing; nuclear mrna splicing, via spliceosome
NM_020187 DC12 11.98 DC12 protein
NM_000895 LTA4H 11.95 Leukotriene A4 hydrolase Inflammatory response; leukotriene biosynthesis;
proteolysis and peptidolysis
NM_003288 TPD52L2 11.87 Tumor protein D52-like 2 Cell proliferation
NM_014501 E2-EPF 11.85 Ubiquitin-conjugating enzyme E2S Ubiquitin cycle
NM_022036 GPRC5C 11.84 G protein-coupled receptor, family C,
group 5, member C
G-protein coupled receptor protein signaling pathway
NM_002643 PIGF 11.7 Phosphatidylinositol glycan, class F
(mitochondrial 3-oxoacyl-Coenzyme A thiolase)
GPI anchor biosynthesis
NM_006111 ACAA2 11.63 Acetyl-Coenzyme A acyltransferase 2 Fatty acid metabolism
NM_018955 UBB 11.58 Ubiquitin B
NM_004642 CDK2AP1 11.56 CDK2-associated protein 1 DNA-dependent DNA replication; S phase of mitotic
cell cycle; negative regulation of cell cycle; protein
amino acid phosphorylation
BE967375 RANBP9 11.51 RAN binding protein 9
NM_012103 AUP1 11.48 Ancient ubiquitous protein 1 Metabolism
U86453 PIK3CD 11.39 Phosphoinositide-3-kinase, catalytic,
delta polypeptide
Protein amino acid phosphorylation;
signal transduction
AK025586 SPATA13 11.31 Spermatogenesis associated 13
NM_015908 ARS2 11.25 Arsenate resistance protein ARS2 Response to arsenic
NM_021178 HEI10 11.25 Cyclin B1 interacting protein 1 Ubiquitin cycle
NM_016615 SLC6A13 11.23 Solute carrier family 6 (neurotransmitter
transporter, GABA), member 13
Neurotransmitter transport
M94345 CAPG 11.17 Capping protein (actin filament), gelsolin-like Protein complex assembly; response to
pest/pathogen/parasite
NM_017710 FLJ20203 11.17 Synonyms: FLJ12923, FLJ23040, KIAA1606,
dkfzp761i241; Homo sapiens hypothetical protein
FLJ20203 (FLJ20203), mrna.
NM_052861 MGC21675 11.05 Hypothetical protein MGC21675
S68616 SLC9A1 11.03 Solute carrier family 9 (sodium/hydrogen exchanger),
isoform 1 (antiporter, Na+/H+, amiloride sensitive)
Regulation of ph; sodium ion transport
NM_018845 LOC55974 11.03 Stromal cell protein
AL117440 PDPR 11.01 Pyruvate dehydrogenase phosphatase regulatory subunit Electron transport
BM467642 SNTB2 10.91 Syntrophin, beta 2 (dystrophin-associated protein
A1, 59 kDa, basic component 2)
NM_003968 UBE1C 10.90 Ubiquitin-activating enzyme E1C
(UBA3 homolog, yeast)
Proteolysis and peptidolysis; ubiquitin cycle
NM_003916 AP1S2 10.88 Adaptor-related protein complex 1, sigma 2 subunit Endocytosis; intracellular protein transport
NM_001799 CDK7 10.88 Cyclin-dependent kinase 7 (MO15 homolog,
Xenopus laevis, cdk-activating kinase)
DNA repair; cytokinesis; protein amino acid
phosphorylation; regulation of cyclin dependent protein
kinase activity; regulation of transcription,
DNA-dependent; transcription initiation from
Pol II promoter
NM_005596 NFIB 10.85 Nuclear factor I/B DNA replication; regulation of transcription,
DNA-dependent
AL834255 DKFZp586M1819 10.84 Putative lysophosphatidic acid acyltransferase Metabolism
NM_018482 DDEF1 10.77 Synonyms: PAP, PAG2, ASAP1, ZG14P,
KIAA1249; Homo sapiens development
and differentiation enhancing factor
1 (DDEF1), mrna.
Regulation of gtpase activity
NM_030577 MGC10993 10.71 Hypothetical protein MGC10993
NM_022095 ZNF335 10.69 Zinc finger protein 335 Regulation of transcription, DNA-dependent
NM_006410 HTATIP2 10.66 HIV-1 Tat interactive protein 2, 30 kDa Anti-apoptosis; induction of apoptosis; regulation
of transcription from Pol II promoter
NM_015332 KIAA1068 10.63 KIAA1068 protein
NM_080820 HARS2 10.48 Histidyl-trna synthetase 2 D-amino acid catabolism
M23161 MCFD2; F5F8D;
SDNSF;
LMAN1IP
10.48 Human transposon-like element mrna. Protein transport
NM_015510 DKFZp566O084 10.47 DKFZP566O084 protein Metabolism
NM_014186 HSPC166 10.46 COMM domain containing 9
NM_001515 GTF2H2 10.46 General transcription factor IIH,
polypeptide 2, 44 kDa
DNA repair; regulation of transcription,
DNA-dependent
NM_003021 SGT 10.44 Small glutamine-rich tetratricopeptide
repeat (TPR)-containing, alpha
Biological_process unknown
L48722 PTP4A2 10.40 Homo sapiens (clone hh18) protein tyrosine
phosphatase (ptp-IV1r) gene, 5′ end of cds.
Protein amino acid dephosphorylation
NM_013393 FTSJ2 10.38 Ftsj homolog 2 (E. Coli) Rrna processing
NM_006191 PA2G4 10.33 Proliferation-associated 2G4, 38 kDa Cell cycle arrest; cell proliferation; proteolysis
and peptidolysis
NM_016628 WAC 10.29 WW domain containing adaptor with coiled-coil
NM_007269 STXBP3 10.26 Syntaxin binding protein 3 Intracellular protein transport; protein secretion
NM_018091 ELP3 10.24 Elongation protein 3 homolog (S. cerevisiae) ATP synthesis coupled proton transport
NM_018182 FLJ10700 10.22 Hypothetical protein FLJ10700
NM_032689 MGC13071 10.22 Hypothetical protein MGC13071 DNA metabolism; regulation of transcription,
DNA-dependent
NM_003759 SLC4A4 10.20 Solute carrier family 4, sodium bicarbonate
cotransporter, member 4
Anion transport
NM_032025 CDA02 10.14 Eukaryotic translation initiation factor (eif) 2A Regulation of protein biosynthesis; ribosome assembly
NM_052935 MGC20781 10.14 Hypothetical protein MGC20781
BC014130 FBXW5 10.12 F-box and WD-40 domain protein 5 Ubiquitin cycle
NM_022039 SHFM3 10.11 Split hand/foot malformation (ectrodactyly) type 3 Wnt receptor signaling pathway; development;
embryonic limb morphogenesis; ubiquitin-dependent
protein catabolism
NM_024868 FLJ14124 10.10 Hypothetical protein FLJ14124
NM_024033 MGC5242 10.09 Hypothetical protein MGC5242
NM_001640 APEH 10.06 N-acylaminoacyl-peptide hydrolase Proteolysis and peptidolysis
NM_000528 MAN2B1 10.05 Mannosidase, alpha, class 2B, member 1 Carbohydrate metabolism; protein deglycosylation;
protein modification
M93718 NOS3 10.01 Nitric oxide synthase 3 (endothelial cell) Amino acid metabolism; cell motility; electron
transport; nitric oxide biosynthesis
NM_016930 STX18 9.98 Syntaxin 18 ER to Golgi transport; intracellular protein transport;
vesicle docking during the process of exocytosis
NM_014311 SMUG1 9.96 Single-strand selective monofunctional uracil
DNA glycosylase
DNA repair
NM_003187 TAF9 9.94 TAF9 RNA polymerase II, TATA box binding
protein (TBP)-associated factor, 32 kDa
Regulation of transcription, DNA-dependent;
transcription from Pol II promoter;
transcription initiation
BC004170 POLE3 9.92 Polymerase (DNA directed), epsilon 3
(p17 subunit)
DNA replication
NM_014323 ZNF278 9.89 Zinc finger protein 278 Cell growth and/or maintenance; regulation of
transcription, DNA-dependent
NM_003678 PK1.3 9.88 Synonyms: Fmip, PK1.3; gene from NF2/
meningioma region of 22q12; placental protein
39.2; go_function: tumor suppressor [goid
0008181] [evidence TAS] [pmid 8242058];
Homo sapiens chromosome 22 open reading
frame 19 (c22orf19), mrna.
NM_013232 PDCD6 9.85 Programmed cell death 6 Apoptosis; induction of apoptosis by
extracellular signals
NM_003782 B3GALT4 9.79 UDP-Gal:betaglcnac beta 1,3-
galactosyltransferase, polypeptide 4
Protein amino acid glycosylation
NM_014920 KIAA0936 9.72 Intestinal cell (MAK-like) kinase Protein amino acid phosphorylation
NM_018106 FLJ10479 9.71 Zinc finger, DHHC domain containing 4
NM_003849 SUCLG1 9.70 Succinate-coa ligase, GDP-forming, alpha subunit Glycolysis; metabolism; tricarboxylic acid cycle
NM_032907 MGC14421 9.69 Bone marrow stromal cell-derived ubiquitin-like Protein modification
NM_005726 TSFM 9.66 Ts translation elongation factor, mitochondrial Protein biosynthesis; translational elongation
NM_014046 MRPS18B 9.63 Mitochondrial ribosomal protein S18B Protein biosynthesis
NM_003364 UP 9.61 Uridine phosphorylase 1 Nucleoside metabolism
NM_003017 SFRS3 9.49 Splicing factor, arginine/serine-rich 3 Nuclear mrna splicing, via spliceosome
NM_006570 RAGA 9.47 Ras-related GTP binding A Cell death; cell growth and/or maintenance; cell surface
receptor linked signal transduction
NM_006339 HMG20B 9.36 High-mobility group 20B Establishment and/or maintenance of chromatin
architecture; regulation of transcription,
DNA-dependent
AB058716 KIAA1813 9.36 Start codon is not identified.; Homo sapiens
mrna for KIAA1813 protein, partial cds.
Superoxide metabolism
NM_020199 HTGN29 9.35 HTGN29 protein
AK021789 LOC146174 9.33 Hypothetical protein LOC146174
NM_007008 RTN4 9.32 Reticulon 4 Negative regulation of anti-apoptosis; negative
regulation of axon extension; regulation of apoptosis
NM_001205 BNIP1 9.27 BCL2/adenovirus E1B 19 kDa interacting protein 1 Anti-apoptosis
NM_005057 RBBP5 9.22 Retinoblastoma binding protein 5
BF698884 DC2 9.21 DC2 protein
NM_004728 DDX21 9.20 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21
NM_014341 MTCH1 9.20 Mitochondrial carrier homolog 1 (C. elegans) Caspase activation; ion channel clustering;
positive regulation of apoptosis; regulation of
signal transduction; transport
NM_006325 RAN 9.20 RAN, member RAS oncogene family DNA metabolism; RNA-nucleus export; intracellular
protein transport; mitotic spindle assembly;
protein-nucleus export; regulation of cell cycle;
signal transduction; small gtpase mediated
signal transduction
NM_018107 FLJ10482 9.18 RNA-binding region (RNP1, RRM) containing 4 Mrna processing
BC012795 CAMK2G 9.15 Calcium/calmodulin-dependent protein kinase
(cam kinase) II gamma
Insulin secretion; protein amino acid phosphorylation
NM_001424 EMP2 9.15 Epithelial membrane protein 2 Cell death; cell proliferation; development
BQ889085 KIAA1164 9.15 Hypothetical protein KIAA1164
NM_006917 RXRG 9.10 Retinoid X receptor, gamma Regulation of transcription, DNA-dependent
NM_005167 ARHC 9.04 Ras homolog gene family, member C
NM_002694 POLR2C 8.98 Polymerase (RNA) II (DNA directed)
polypeptide C, 33 kDa
Transcription; transcription from Pol II promoter
NM_017582 HSA243666 8.95 Ubiquitin-conjugating enzyme E2Q (putative) Ubiquitin cycle
NM_005141 FGB 8.93 Fibrinogen, B beta polypeptide Blood coagulation; positive regulation of cell
proliferation; regulation of blood pressure
NM_001631 ALPI 8.91 Alkaline phosphatase, intestinal Metabolism; phosphorylation
NM_014371 NAKAP95 8.87 A kinase (PRKA) anchor protein 8-like Biological_process unknown
NM_032280 DKFZp761J139 8.86 Zinc finger, CCHC domain containing 9
NM_004128 GTF2F2 8.81 General transcription factor IIF,
polypeptide 2, 30 kDa
RNA elongation from Pol II promoter; regulation of
transcription, DNA-dependent; transcription
initiation from Pol II promoter
NM_017542 KIAA1513 8.79 Pogo transposable element with KRAB domain Anti-apoptosis
NM_004725 BUB3 8.75 BUB3 budding uninhibited by benzimidazoles
3 homolog (yeast)
Cell proliferation; mitosis; mitotic spindle checkpoint
NM_006868 RAB31 8.75 RAB31, member RAS oncogene family Small gtpase mediated signal transduction
NM_025267 MGC2744 8.73 Hypothetical protein MGC2744 Alanyl-trna aminoacylation
AL137398 DKFZp434P162 8.73 Similar to hypothetical protein (LOC388094), mrna
AB033041 VANGL2 8.73 Vang-like 2 (van gogh, Drosophila)
NM_006357 UBE2E3 8.72 Ubiquitin-conjugating enzyme E2E 3 (UBC4/5
homolog, yeast)
Ubiquitin cycle
AK056862 MPHOSPH10 8.70 M-phase phosphoprotein 10 (U3 small nucleolar
ribonucleoprotein)
Rrna processing
NM_018235 FLJ10830 8.67 Cytosolic nonspecific dipeptidase (EC 3.4.13.18) Proteolysis and peptidolysis
NM_006925 SFRS5 8.64 Splicing factor, arginine/serine-rich 5 Mrna splice site selection; nuclear mrna splicing,
via spliceosome
AJ224162 LIAS 8.63 Lipoic acid synthetase Lipoate biosynthesis
NM_001069 TUBB 8.62 Tubulin, beta polypeptide
NM_013989 DIO2 8.61 Deiodinase, iodothyronine, type II Thyroid hormone generation
NM_152417 FLJ32370 8.60 Hypothetical protein FLJ32370 Metabolism
NM_016943 TAS2R3 8.59 Taste receptor, type 2, member 3 G-protein coupled receptor protein signaling pathway;
perception of taste; signal transduction
NM_014335 CRI1 8.55 CREBBP/EP300 inhibitory protein 1 Biological_process unknown
NM_018842 LOC55971 8.55 Insulin receptor tyrosine kinase substrate
NM_021826 FLJ13149 8.48 Homo sapiens hypothetical protein FLJ13149
(FLJ13149), mrna.
Apoptosis
AL832304 SLC9A9 8.48 Solute carrier family 9 (sodium/hydrogen
exchanger), isoform 9
Regulation of ph; sodium ion transport
NM_002027 FNTA 8.47 Farnesyltransferase, CAAX box, alpha Protein amino acid farnesylation; protein amino acid
geranylgeranylation; protein amino acid prenylation;
transforming growth factor beta receptor
signaling pathway
NM_005102 FEZ2 8.46 Fasciculation and elongation protein
zeta 2 (zygin II)
Axon guidance; hemopoiesis; neurogenesis;
signal transduction
NM_030798 WBSCR16 8.46 Williams-Beuren syndrome chromosome
region 16
Biological_process unknown
NM_003213 TEAD4 8.44 TEA domain family member 4 Regulation of transcription, DNA-dependent
NM_002431 MNAT1 8.40 Menage a trois 1 (CAK assembly factor) DNA repair; cell cycle; protein complex assembly;
regulation of cyclin dependent protein kinase activity;
regulation of transcription from Pol II promoter
NM_002015 FOXO1A 8.38 Forkhead box O1A (rhabdomyosarcoma) Anti-apoptosis; cell growth and/or maintenance;
regulation of transcription from Pol II promoter
NM_002221 ITPKB 8.37 Inositol 1,4,5-trisphosphate 3-kinase B Signal transduction
NM_017832 FLJ20457 8.35 Hypothetical protein FLJ20457
NM_002808 PSMD2 8.30 Proteasome (prosome, macropain) 26S
subunit, non-atpase, 2
Regulation of cell cycle
AB002313 PLXNB2 8.26 Plexin B2 Development
NM_004462 FDFT1 8.23 Farnesyl-diphosphate farnesyltransferase 1 Biosynthesis; cholesterol biosynthesis; isoprenoid
biosynthesis; steroid biosynthesis
NM_002109 HARS 8.23 Histidyl-trna synthetase Histidyl-trna aminoacylation; protein biosynthesis
NM_024330 SLC27A3 8.22 Solute carrier family 27 (fatty acid transporter),
member 3
Metabolism
NM_020350 AGTRAP 8.15 Angiotensin II receptor-associated protein
NM_001288 CLIC1 8.15 Chloride intracellular channel 1 Chloride transport; ion transport
N28741 HIPK2 8.15 Homeodomain interacting protein kinase 2
NM_004044 ATIC 8.09 5-Aminoimidazole-4-carboxamide ribonucleotide
formyltransferase/IMP cyclohydrolase
Nucleobase, nucleoside, nucleotide and nucleic
acid metabolism; purine nucleotide biosynthesis
AF052148 G22P1 8.09 Thyroid autoantigen 70 kDa (Ku antigen)
AL050205 LOC113251 8.08 C-Mpl binding protein
AF250920 FOXP1 8.08 Forkhead box P1 Regulation of transcription, DNA-dependent
BC001855 WASF2 8.08 WAS protein family, member 2
NM_003311 TSSC3 8.07 Pleckstrin homology-like domain, family A, member 2 Apoptosis; imprinting
AV650362 SFRS6 8.01 Splicing factor, arginine/serine-rich 6
NM_018492 TOPK 8.00 T-LAK cell-originated protein kinase Protein amino acid phosphorylation
X80199 MLN51 7.98 Cancer susceptibility candidate 3 Biological_process unknown
NM_007031 HSF2BP 7.94 Heat shock transcription factor 2 binding protein Spermatogenesis; transcription from Pol II promoter
NM_002254 KIF3C 7.88 Kinesin family member 3C Microtubule-based movement
NM_002481 PPP1R12B 7.88 Protein phosphatase 1, regulatory
(inhibitor) subunit 12B
Regulation of muscle contraction; signal transduction
NM_004701 CCNB2 7.83 Cyclin B2 Cytokinesis; mitosis; regulation of cell cycle
NM_001722 BN51T 7.79 Polymerase (RNA) III (DNA directed)
polypeptide D, 44 kDa
Regulation of cell cycle; trna metabolism; transcription
NM_004356 CD81 7.78 CD81 antigen (target of antiproliferative
antibody 1)
Activation of MAPK; phosphatidylinositol biosynthesis;
phosphoinositide metabolism; positive regulation of
1-phosphatidylinositol 4-kinase activity; positive
regulation of B-cell proliferation; positive regulation of
cell proliferation; positive regulation of
peptidyl-tyrosine phosphorylation; protein localization;
viral entry into host cell; virion attachment, binding
of host cell surface receptor
NM_018983 NOLA1 7.77 Nucleolar protein family A, member 1
(H/ACA small nucleolar rnps)
Rrna processing
NM_003091 SNRPB 7.74 Small nuclear ribonucleoprotein
polypeptides B and B1
RNA splicing; nuclear mrna splicing, via spliceosome
NM_022831 FLJ12806 7.72 Hypothetical protein FLJ12806
NM_005701 RNUT1 7.72 RNA, U transporter 1
NM_138443 LOC115106 7.7 Coiled-coil domain containing 5 (spindle associated) Cell cycle; cytokinesis; mitosis
AL157442 GRINA 7.69 Glutamate receptor, ionotropic, N-methyl D-
asparate-associated protein 1 (glutamate binding)
NM_004269 CRSP8 7.68 Cofactor required for Sp1 transcriptional
activation, subunit 8, 34 kDa
Regulation of transcription from Pol II promoter;
transcription initiation from Pol II promoter
NM_002149 HPCAL1 7.67 Hippocalcin-like 1 Vesicle-mediated transport
NM_016033 CGI-90 7.64 CGI-90 protein
NM_001398 ECH1 7.64 Enoyl Coenzyme A hydratase 1, peroxisomal Energy pathways; fatty acid beta-oxidation;
fatty acid metabolism
NM_001513 GSTZ1 7.64 Glutathione transferase zeta 1
(maleylacetoacetate isomerase)
Aromatic amino acid family metabolism; phenylalanine
catabolism; tyrosine catabolism
NM_024662 FLJ10774 7.64 N-acetyltransferase-like protein Biological_process unknown
BC015882 EZH1;HGS 7.62 Enhancer of zeste homolog 1 (Drosophila) Morphogenesis; regulation of transcription,
DNA-dependent
NM_024619 FLJ12171 7.58 Fructosamine-3-kinase-related protein
NM_002911 RENT1 7.57 Regulator of nonsense transcripts 1 Mrna catabolism, nonsense-mediated; regulation of
translational termination
AJ005866 SQV7L 7.55 Solute carrier family 35, member D2 Biological_process unknown
AL834255 DKFZp586M1819 7.53 Putative lysophosphatidic acid acyltransferase Metabolism
NM_016491 MRPL37 7.50 Mitochondrial ribosomal protein L37 Electron transport; response to oxidative stress
NM_000070 CAPN3 7.49 Calpain 3, (p94) Muscle development; proteolysis and peptidolysis
NM_003642 HAT1 7.48 Histone acetyltransferase 1 DNA packaging; internal protein
amino acid acetylation
NM_006561 CUGBP2 7.47 CUG triplet repeat, RNA binding protein 2 RNA processing; neuromuscular junction development;
regulation of heart rate
NM_020117 FLJ10595 7.44 Leucyl-trna synthetase Protein biosynthesis; trna aminoacylation for protein
translation
NM_006590 SAD1 7.43 Ubiquitin specific protease 39 RNA splicing; mrna processing; spliceosome assembly;
ubiquitin-dependent protein catabolism
NM_006349 CG1I 7.40 Zinc finger, HIT domain containing 1
NM_014251 SLC25A13 7.39 Solute carrier family 25, member 13 (citrin) Transport
NM_018706 KIAA1630 7.36 Dehydrogenase E1 and transketolase
domain containing 1
Metabolism
NM_032361 MGC5469 7.34 THO complex 3 Mrna-nucleus export; nuclear mrna splicing,
via spliceosome; transport
BC003353 MGC5309 7.33 Hypothetical protein MGC5309
NM_057158 DUSP4 7.30 Dual specificity phosphatase 4 MAPKKK cascade; protein amino acid
dephosphorylation; regulation of cell cycle
NM_006451 PAIP1 7.29 Poly(A) binding protein interacting protein 1 Protein biosynthesis
NM_030813 SKD3 7.29 Suppressor of potassium transport defect 3
NM_001098 ACO2 7.27 Aconitase 2, mitochondrial Citrate metabolism; energy pathways; tricarboxylic
acid cycle
NM_032527 KIAA1847 7.26 Kiaa1847
M96739 NHLH1 7.20 Nescient helix loop helix 1 Cell differentiation; central nervous system development;
regulation of transcription, DNA-dependent
NM_013374 PDCD6IP 7.19 Programmed cell death 6 interacting protein Apoptosis; signal transduction
NM_005572 LMNA 7.18 Lamin A/C Muscle development
NM_016447 LOC51678 7.16 Membrane protein, palmitoylated 6
(MAGUK p55 subfamily member 6)
Protein complex assembly
NM_004132 HABP2 7.15 Hyaluronan binding protein 2 Cell adhesion; proteolysis and peptidolysis
NM_002814 PSMD10 7.14 Proteasome (prosome, macropain)
26S subunit, non-atpase, 10
NM_014629 ARHGEF10 7.14 Rho guanine nucleotide exchange factor (GEF) 10
NM_003707 RUVBL1 7.14 Ruvb-like 1 (E. Coli) DNA recombination; regulation of transcription from
Pol II promoter; spermatogenesis
NM_014551 384D8-2 7.13 Hypothetical protein 384D8_6
AL365410 LOC56930 7.12 Clone IMAGE:4441633, mrna
NM_024863 FLJ21174 7.08 Hypothetical protein FLJ21174
NM_001358 DDX15 7.07 DEAH (Asp-Glu-Ala-His) box polypeptide 15 Nuclear mrna splicing, via spliceosome
NM_138615 DDX30 7.04 DEAH (Asp-Glu-Ala-His) box polypeptide 30
BG497672 CD44 7.03 CD44 antigen (homing function and Indian blood group system)
AB020626 KIAA0819 6.98 KIAA0819 protein
BE818483 ATP1B3 6.96 Atpase, Na+/K+ transporting, beta 3 polypeptide
NM_032122 DTNBP1 6.95 Dystrobrevin binding protein 1 Visual perception
BC021565 SNX8 6.94 Sorting nexin 8 Intracellular protein transport; intracellular
signaling cascade
NM_025199 FLJ20886 6.94 Synonyms: ASH, Grb3-3, EGFRBP-GRB2;
isoform 1 is encoded by transcript variant 1;
HT027; growth factor receptor-bound protein 3;
epidermal growth factor receptor-binding
protein GRB2; abundant SRC homology;
go_function: SH3/SH2 adaptor protein activity
[goid 0005070] [evidence TAS] [pmid 8253073];
go_process: epidermal growth factor receptor
signaling pathway [goid 0007173] [evidence
TAS] [pmid 1322798]; go_process: RAS protein
signal transduction [goid 0007265] [evidence
TAS] [pmid 8253073]; go_process: cell shape
and cell size control [goid 0007148] [evidence E];
go_process: cell-cell signaling [goid 0007267]
[evidence TAS] [pmid 8253073]; go_process:
intracellular signaling cascade [goid 0007242]
[evidence IEA]; Homo sapiens growth factor
receptor-bound protein 2 (GRB2), transcript
variant 1, mrna.
NM_021639 SP192 6.92 Hypothetical protein SP192
NM_001333 CTSL2 6.87 Cathepsin L2 Proteolysis and peptidolysis
D29641 KIAA0052 6.86 KIAA0052 protein
AK094458 WBP2 6.86 Unnamed protein product; Homo sapiens cdna
FLJ37139 fis, clone BRACE2023727, weakly
similar to Human WW domain binding
protein-2 mrna.
NM_014468 VENTX2 6.86 VENT-like homeobox 2 Regulation of transcription, DNA-dependent
NM_001769 CD9 6.84 CD9 antigen (p24) Cell adhesion; cell motility; fusion of sperm
to egg plasma membrane; paranodal junction
formation; platelet activation
NM_002980 SCTR 6.83 Secretin receptor G-protein coupled receptor protein signaling pathway;
digestion; excretion
NM_014907 KIAA0967 6.79 FERM and PDZ domain containing 1
NM_030673 SEC13L1 6.79 SEC13-like 1 (S. cerevisiae) Intracellular protein transport
NM_007126 VCP 6.78 Valosin-containing protein Transport
NM_017957 FLJ20778 6.77 Epsin 3
NM_004741 NOLC1 6.77 Nucleolar and coiled-body phosphoprotein 1 Cell cycle; mitosis; rrna processing
NM_012321 LSM4 6.75 LSM4 homolog, U6 small nuclear RNA
associated (S. cerevisiae)
RNA splicing; nuclear mrna splicing, via spliceosome
NM_015638 C20orf188 6.74 Transient receptor potential cation channel,
subfamily C, member 4 associated protein
Antigen presentation, endogenous peptide antigen;
antigen processing, endogenous antigen via MHC class
I; cytosol to ER transport; intracellular protein
transport; peptide transport; protein complex assembly
NM_024960 PANK2 6.73 Pantothenate kinase 2
(Hallervorden-Spatz syndrome)
Coenzyme A biosynthesis
NM_000392 ABCC2 6.72 ATP-binding cassette, sub-family C
(CFTR/MRP), member 2
Transport
NM_005918 MDH2 6.72 Malate dehydrogenase 2, NAD (mitochondrial) Tricarboxylic acid cycle
NM_003795 SNX3 6.71 Sorting nexin 3 Endocytosis; intracellular protein transport;
intracellular signaling cascade
AK025687 JRK 6.70 Jerky homolog (mouse) Biological_process unknown
AK056268 SHD 6.69 Src homology 2 domain-containing
transforming protein D
Intracellular signaling cascade
NM_022839 MRPS11 6.64 Mitochondrial ribosomal protein S11 Protein biosynthesis
NM_004896 VPS26 6.62 Vacuolar protein sorting 26 (yeast) Intracellular protein transport; retrograde
transport, endosome to Golgi
NM_017907 FLJ20625 6.57 Hypothetical protein FLJ20625 Regulation of transcription, DNA-dependent
NM_023080 FLJ20989 6.57 Hypothetical protein FLJ20989
NM_032038 LOC83985 6.57 Spinster-like Transport
NM_003754 EIF3S5 6.55 Eukaryotic translation initiation factor 3,
subunit 5 epsilon, 47 kDa
Protein biosynthesis; regulation of translational
initiation
AB002360 MCF2L 6.54 MCF.2 cell line derived transforming
sequence-like
Cell growth and/or maintenance; intracellular
signaling cascade
AB033001 FLJ10209 6.54 Phosphofurin acidic cluster sorting protein 1
AK093442 ZNF596 6.54 Zinc finger protein 596
NM_005444 RQCD1 6.53 RCD1 required for cell differentiation1
homolog (S. Pombe)
Sex differentiation
NM_015994 ATP6M 6.49 Atpase, H+ transporting, lysosomal
34 kDa, V1 subunit D
ATP synthesis coupled proton transport
BF984906 LOC199800 6.44 Hypothetical protein LOC199800
NM_001102 ACTN1 6.43 Actinin, alpha 1
NM_005032 PLS3 6.42 Plastin 3 (T isoform)
NM_017934 PHIP 6.42 Pleckstrin homology domain interacting protein Insulin receptor signaling pathway
U40271 PTK7 6.42 PTK7 protein tyrosine kinase 7 Cell adhesion; protein amino acid phosphorylation;
signal transduction
NM_007103 NDUFV1 6.40 NADH dehydrogenase (ubiquinone)
flavoprotein 1, 51 kDa
Energy pathways; mitochondrial electron
transport, NADH to ubiquinone
NM_004716 PCSK7 6.40 Proprotein convertase subtilisin/kexin type 7 Peptide hormone processing; proteolysis
and peptidolysis
NM_000116 TAZ 6.39 Tafazzin (cardiomyopathy, dilated 3A
(X-linked); endocardial fibroelastosis 2;
Barth syndrome)
Heart development; metabolism; muscle
contraction; muscle development
NM_000137 FAH 6.38 Fumarylacetoacetate hydrolase
(fumarylacetoacetase)
Aromatic amino acid family metabolism; phenylalanine
catabolism; tyrosine catabolism
NM_001611 ACP5 6.36 Acid phosphatase 5, tartrate resistant
NM_001130 AES 6.36 Amino-terminal enhancer of split Wnt receptor signaling pathway; development;
organogenesis; regulation of transcription,
DNA-dependent
NM_020410 CGI-152 6.35 Atpase type 13A Cation transport; metabolism
NM_006838 METAP2 6.35 Methionyl aminopeptidase 2 Protein modification; proteolysis and peptidolysis;
regulation of translation
NM_014254 TMEM5 6.32 Transmembrane protein 5
NM_024960 PANK2 6.30 Pantothenate kinase 2
(Hallervorden-Spatz syndrome)
Coenzyme A biosynthesis
NM_016016 CGI-69 6.29 CGI-69 protein Transport
NM_001662 ARF5 6.28 ADP-ribosylation factor 5 Intracellular protein transport; small gtpase
mediated signal transduction
NM_080476 CDC91L1 6.27 CDC91 cell division cycle 91-like 1 (S. cerevisiae) GPI anchor biosynthesis
NM_002887 RARS 6.26 Arginyl-trna synthetase Arginyl-trna aminoacylation; protein biosynthesis
NM_002414 MIC2 6.26 CD99 antigen Cell adhesion
AF183421 RAB31 6.26 RAB31, member RAS oncogene family Small gtpase mediated signal transduction
NM_002571 PAEP 6.24 Progestagen-associated endometrial protein
(placental protein 14, pregnancy-associated
endometrial alpha-2-globulin, alpha
uterine protein)
Development; transport
NM_003574 VAPA 6.22 VAMP (vesicle-associated membrane protein)-
associated protein A, 33 kDa
Positive regulation of I-kappab kinase/NF-kappab
cascade
NM_006523 XPNPEPL 6.20 Synonyms: SAMP, XPNPEP, XPNPEPL;
X-prolyl aminopeptidase (aminopeptidase P)-like;
go_function: aminopeptidase activity [goid 0004177]
[evidence P]; Homo sapiens X-prolyl aminopeptidase
(aminopeptidase P) 1, soluble (XPNPEP1), mrna.
NM_018263 FLJ10898 6.17 Additional sex combs like 2 (Drosophila)
Z70703 LOC166994 6.17 Similar to ba110h4.2 (similar to membrane
protein) (LOC389281), mrna
NM_003077 SMARCD2 6.16 SWI/SNF related, matrix associated, actin
dependent regulator of chromatin,
subfamily d, member 2
Chromatin remodeling; regulation of
transcription from Pol II promoter
NM_003977 AIP 6.15 Aryl hydrocarbon receptor interacting protein Protein folding
AK027249 CAPN3 6.15 Calpain 3, (p94) Muscle development; proteolysis and peptidolysis
AB018297 KIAA0754 6.15 KIAA0754 protein
AK000300 ATP2A2 6.14 Atpase, Ca++ transporting, cardiac
muscle, slow twitch 2
NM_004229 CRSP2 6.14 Cofactor required for Sp1 transcriptional
activation, subunit 2, 150 kDa
Androgen receptor signaling pathway;
regulation of transcription from Pol II promoter;
transcription initiation from Pol II promoter
AB051469 3-PAP 6.14 Phosphatidylinositol-3-phosphate
associated protein
Phospholipid dephosphorylation
NM_020533 MCOLN1 6.12 Mucolipin 1 Cation transport
NM_005865 PRSS16 6.12 Protease, serine, 16 (thymus) Proteolysis and peptidolysis
NM_004461 FARSL 6.11 Phenylalanine-trna synthetase-like, alpha subunit Phenylalanyl-trna aminoacylation; protein biosynthesis
NM_021198 NLI-IF 6.10 CTD (carboxy-terminal domain, RNA polymerase
II, polypeptide A) small phosphatase 1
Biological_process unknown
AL833978 HP1-BP74 6.10 Hp1-bp74 Nucleosome assembly
BC000050 ART-4 6.10 Likely ortholog of mouse nin one binding protein
NM_000126 ETFA 6.09 Electron-transfer-flavoprotein, alpha polypeptide
(glutaric aciduria II)
Electron transport
NM_003295 TPT1 6.08 Tumor protein, translationally-controlled 1
NM_002319 LRRN1 6.06 Leucine rich repeat neuronal 4 Neurogenesis
NM_014932 NLGN1 6.02 Neuroligin 1 Calcium-dependent cell-cell adhesion; ion channel
clustering; protein targeting; regulation of neuron
differentiation; synaptic vesicle targeting;
synaptogenesis
NM_013241 FHOD1 6.01 Formin homology 2 domain containing 1 Cell organization and biogenesis
NM_007032 HRIHFB2122 6.01 Tara-like protein Actin modification
NM_001765 CD1C 6.00 CD1C antigen, c polypeptide Antimicrobial humoral response (sensu Vertebrata)
AB051535 DKFZP586K0524 6.00 Zinc finger, DHHC domain containing 5
AA316117 MACF1 5.98 Microtubule-actin crosslinking factor 1
NM_014275 MGAT4B 5.97 Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-
N-acetylglucosaminyltransferase, isoenzyme B
Carbohydrate metabolism
NM_004549 NDUFC2 5.97 NADH dehydrogenase (ubiquinone) 1,
subcomplex unknown, 2, 14.5 kDa
Mitochondrial electron transport, NADH
to ubiquinone
NM_021141 XRCC5 5.97 X-ray repair complementing defective repair
in Chinese hamster cells 5 (double-strand-break
rejoining; Ku autoantigen, 80 kDa)
DNA recombination; double-strand break repair
via nonhomologous end-joining; regulation of
DNA repair
NM_138777 LOC92399 5.96 Mitochondrial ribosome recycling factor Protein biosynthesis
AB007960 SH3GLB1 5.95 SH3-domain GRB2-like endophilin B1 Apoptosis
NM_016059 PPIL1 5.93 Peptidylprolyl isomerase (cyclophilin)-like 1 Protein folding
NM_002768 PCOLN3 5.93 Procollagen (type III) N-endopeptidase Gene silencing; mitotic chromosome condensation;
negative regulation of S phase of mitotic cell cycle;
negative regulation of transcription by glucose; negative
regulation of transcription, DNA-dependent;
vesicle-mediated transport
NM_000930 PLAT 5.92 Plasminogen activator, tissue Blood coagulation; protein modification;
proteolysis and peptidolysis
NM_003002 SDHD 5.89 Succinate dehydrogenase complex, subunit D,
integral membrane protein
Electron transport; tricarboxylic acid cycle
NM_000581 GPX1 5.86 Glutathione peroxidase 1 Response to oxidative stress
AK075559 MGC20446; 5.86 Hypothetical protein MGC20446 Electron transport
NM_016553 NUP62 5.86 Nucleoporin 62 kDa Transport
AK023373 GTR2; 5.84 Ras-related GTP binding C RNA splicing; apoptosis; cell growth; cell growth and/or
maintenance; small gtpase mediated
signal transduction; transcription
NM_005626 SFRS4 5.84 Splicing factor, arginine/serine-rich 4 RNA splicing; nuclear mrna splicing, via spliceosome
AJ237724 SLC19A2 5.82 Solute carrier family 19
(thiamine transporter), member 2
Perception of sound; thiamin transport
NM_014730 KIAA0152 5.81 Go_component: integral to membrane
[goid 0016021] [evidence IEA]; Homo sapiens
KIAA0152 gene product (KIAA0152), mrna.
NM_006164 NFE2L2 5.80 Nuclear factor (erythroid-derived 2)-like 2 Regulation of transcription, DNA-dependent;
transcription from Pol II promoter
NM_006196 PCBP1 5.77 Poly(rc) binding protein 1 Mrna metabolism
NM_139178 DEPC-1 5.76 Prostate cancer antigen-1
AK026920 MYO1D 5.75 Myosin ID
NM_004814 HPRP8BP 5.75 U5 snrnp-specific 40 kDa protein (hprp8-binding) RNA splicing; nuclear mrna splicing, via spliceosome
AK026373 HNRPA2B1 5.74 Heterogeneous nuclear ribonucleoprotein A2/B1
NM_002123 HLA-DQB1 5.73 Major histocompatibility complex, class II,
DQ beta 1
Antigen presentation, exogenous antigen;
antigen processing, exogenous antigen via MHC
class II; immune response
AB046815 KIAA1595; 5.72 DEAD (Asp-Glu-Ala-Asp) box polypeptide 55
AA318395 MRLC2 5.72 Myosin regulatory light chain MRLC2
NM_003562 SLC25A11 5.70 Solute carrier family 25 (mitochondrial carrier;
oxoglutarate carrier), member 11
Transport
NM_003485 GPR68 5.69 G protein-coupled receptor 68 G-protein coupled receptor protein signaling pathway;
inflammatory response
NM_001731 BTG1 5.68 B-cell translocation gene 1, anti-proliferative Cell proliferation; negative regulation of
cell proliferation
NM_003145 SSR2 5.67 Signal sequence receptor, beta
(translocon-associated protein beta)
Cotranslational membrane targeting
NM_019100 DMAP1 5.66 DNA methyltransferase 1 associated protein 1 DNA methylation; chromatin modification;
negative regulation of transcription; regulation of
cell growth; regulation of transcription,
DNA-dependent
NM_006811 TDE1 5.66 Tumor differentially expressed 1
AB023166 CIT 5.65 Citron (rho-interacting, serine/threonine
kinase 21)
Intracellular signaling cascade; protein
amino acid phosphorylation
NM_003769 SFRS9 5.65 Splicing factor, arginine/serine-rich 9 Mrna splice site selection; nuclear mrna splicing,
via spliceosome
NM_031213 MGC:5244 5.63 Hypothetical protein MGC5244
NM_001757 CBR1 5.62 Carbonyl reductase 1 Metabolism
NM_003364 UP 5.62 Uridine phosphorylase 1 Nucleoside metabolism
BC020243 SSH1 5.58 Slingshot 1
NM_015957 LOC51074 5.57 Likely ortholog of mouse monocyte macrophage 19
NM_016038 CGI-97 5.56 Shwachman-Bodian-Diamond syndrome
NM_004904 H_GS165L15.1 5.55 Camp responsive element binding protein 5 Positive regulation of transcription, DNA-dependent;
transcription from Pol II promoter
NM_023077 FLJ12439 5.55 Hypothetical protein FLJ12439
NM_014369 PTPN18 5.55 Protein tyrosine phosphatase, non-receptor
type 18 (brain-derived)
Protein amino acid dephosphorylation
AF212303 GSTTLp28 5.54 Glutathione S-transferase omega 1 Metabolism
NM_004070 CLCNKA 5.52 Chloride channel Ka Chloride transport; excretion; ion transport
U47077 PRKDC 5.52 Protein kinase, DNA-activated,
catalytic polypeptide
DNA recombination; double-strand break repair;
protein modification
NM_006809 TOMM34 5.51 Translocase of outer mitochondrial membrane 34 Protein-mitochondrial targeting
NM_004053 BYSL 5.50 Bystin-like Cell adhesion; pregnancy
NM_014370 STK23 5.49 Serine/threonine kinase 23 Protein amino acid phosphorylation
NM_004517 ILK 5.46 Integrin-linked kinase Cell-matrix adhesion; integrin-mediated signaling
pathway; protein amino acid phosphorylation
NM_145255 MRPL10 5.46 Mitochondrial ribosomal protein L10
D43948 KIAA0097 5.45 KIAA0097 gene product Biological_process unknown
NM_032772 MGC2555 5.43 Zinc finger protein 503
NM_003904 ZNF259 5.42 Zinc finger protein 259 Cell proliferation; signal transduction
NM_030782 CRR9 5.41 Cisplatin resistance related protein CRR9p
NM_001532 SLC29A2 5.41 Solute carrier family 29 (nucleoside
transporters), member 2
Cell proliferation; nucleobase, nucleoside, nucleotide
and nucleic acid metabolism; nucleoside transport
NM_022827 FLJ21347 5.40 Hypothetical protein FLJ21347 Carbohydrate metabolism
NM_006303 JTV1 5.39 JTV1 gene Protein biosynthesis
NM_017455 SDFR1 5.33 Stromal cell derived factor receptor 1
NM_018413 C4ST 5.27 Carbohydrate (chondroitin 4) sulfotransferase 11
NM_004582 RABGGTB 5.27 Rab geranylgeranyltransferase, beta subunit Protein modification; visual perception
NM_004550 NDUFS2 5.25 NADH dehydrogenase (ubiquinone) Fe-S
protein 2, 49 kDa (NADH-coenzyme Q reductase)
Electron transport; mitochondrial electron
transport, NADH to ubiquinone
AK023089 SLC30A7 5.21 Solute carrier family 30 (zinc transporter),
member 7
Cation transport
NM_033301 RPL8 5.20 Ribosomal protein L8 Protein biosynthesis
NM_015524 C6orf5 5.20 Synonyms: ACT1, CIKS, c6orf5, c6orf6, MGC3581,
DKFZP586G0522; isoform 2 is encoded by
transcript variant 2; chromosome 6 open reading
frame 6; chromosome 6 open reading frame 5;
connection to IKK and SAPK/JNK; nfkb-
activating protein ACT1; go_component:
cellular_component unknown [goid 0008372]
[evidence ND]; go_function: molecular_function
unknown [goid 0005554] [evidence ND];
go_process: intracellular signaling cascade
[goid 0007242] [evidence NAS] [pmid 10962033];
Homo sapiens chromosome 6 open reading
frame 4 (c6orf4), transcript variant 2, mrna.
NM_004134 HSPA9B 5.18 Heat shock 70 kDa protein 9B (mortalin-2) Protein folding
Down-regulated
AB040935 CerCAM −100.00 Cerebral endothelial cell adhesion molecule 1 Lipopolysaccharide biosynthesis
NM_001482 GATM −100.00 Glycine amidinotransferase
(L-arginine:glycine amidinotransferase)
Creatine biosynthesis
X07263 MYCL1;
LMYC
−100.00 Human l-myc gene exon 3 and 3′-flanking region. Cell growth and/or maintenance; regulation
of transcription, DNA-dependent
L27560 IGFBP5 −100.00 Insulin-like growth factor binding protein 5 Cell growth and/or maintenance; regulation of
cell growth; signal transduction
AB037804 KIAA1383 −100.00 KIAA1383 protein
NM_002357 MAD −100.00 MAX dimerization protein 1 Cell proliferation; development; regulation
of transcription, DNA-dependent
NM_139136 KCNC2 −100.00 Potassium voltage-gated channel,
Shaw-related subfamily, member 2
Cation transport; potassium ion transport
NM_000962 PTGS1 −100.00 Prostaglandin-endoperoxide synthase 1
(prostaglandin G/H synthase and cyclooxygenase)
Lipid metabolism; physiological process;
prostaglandin biosynthesis
AK000416 SLC16A5 −100.00 Solute carrier family 16 (monocarboxylic
acid transporters), member 5
Monocarboxylic acid transport
NM_000543 SMPD1 −100.00 Sphingomyelin phosphodiesterase 1,
acid lysosomal (acid sphingomyelinase)
Carbohydrate metabolism; neurogenesis;
signal transduction; sphingomyelin metabolism
NM_016525 UBAP −100.00 Ubiquitin associated protein 1
NM_005263 GFI1 −87.72 Growth factor independent 1 G1/S-specific transcription in mitotic cell cycle;
viral life cycle
NM_001276 CHI3L1 −84.75 Chitinase 3-like 1 (cartilage glycoprotein-39) Metabolism
AB033076 KIDINS220 −80.00 Likely homolog of rat kinase D-interacting
substance of 220 kDa
Y10183 ALCAM −66.23 Activated leukocyte cell adhesion molecule Antimicrobial humoral response (sensu Vertebrata);
cell adhesion; signal transduction
NM_052944 KST1 −62.89 Sodium/myo-inositol cotransporter 2 Transport
AL080094 RPESP −60.98 RPE-spondin
NM_013448 BAZ1A −48.78 Bromodomain adjacent to zinc finger domain, 1A Protein ubiquitination; regulation of transcription,
DNA-dependent
NM_017936 FLJ20707 −45.87 Kiaa2010 ATP synthesis coupled proton transport; phosphate
transport
NM_013357 PURG −39.37 Werner syndrome
NM_017884 PINX1 −35.21 PIN2-interacting protein 1 Negative regulation of cell cycle; negative regulation
of cell proliferation; telomerase-dependent
telomere maintenance
NM_005900 MADH1;
DKFZP586M0622
−30.67 MAD, mothers against
decapentaplegic homolog 1 (Drosophila)
Regulation of transcription, DNA-dependent;
signal transduction; transforming growth
factor beta receptor signaling pathway
X75489 LIPA −29.24 H.sapiens LIPA gene, exon 1.
M97496 GUCA2A −28.41 Guanylate cyclase activator 2A (guanylin) Signal transduction
AK000462 OCIA −26.74 Ovarian carcinoma immunoreactive antigen
NM_000756 CRH −25.77 Corticotropin releasing hormone Immune response; learning and/or memory;
parturition; pregnancy; signal transduction;
synaptic transmission
NM_130467 PAGE-5 −25.77 PAGE-5 protein
NM_030973 TCBAP0758 −23.70 Hypothetical protein TCBAP0758
NM_018324 FLJ11106 −21.51 Hypothetical protein FLJ11106 Biosynthesis
NM_000961 PTGIS −19.46 Prostaglandin I2 (prostacyclin) synthase Electron transport; lipid metabolism; prostaglandin
biosynthesis
NM_002363 MAGEB1 −16.75 Melanoma antigen, family B, 1
NM_003940 USP13 −16.67 Ubiquitin specific protease 13 (isopeptidase T-3) Ubiquitin-dependent protein catabolism
NM_004284 CHD1L −16.23 Synonyms: CHDL, FLJ22530; go_function: ATP
binding [goid 0005524] [evidence IEA];
go_function: DNA binding [goid 0003677]
[evidence IEA]; go_function: ATP-dependent
helicase activity [goid 0008026] [evidence IEA];
go_function: hydrolase activity [goid 0016787]
[evidence IEA]; Homo sapiens chromodomain
helicase DNA binding protein 1-like
(CHD1L), mrna.
NM_030642 APOL5 −15.77 Apolipoprotein L, 5 Lipid metabolism; lipid transport
AK001640 KIAA0738 −15.77 KIAA0738 gene product
NM_016270 KLF2 −14.53 Kruppel-like factor 2 (lung) Regulation of transcription, DNA-dependent
NM_002390 ADAM11 −13.93 A disintegrin and metalloproteinase domain 11 Integrin-mediated signaling pathway; proteolysis and
peptidolysis
NM_006651 CPLX1 −13.83 Complexin 1 Exocytosis; neurotransmitter transport;
synaptic transmission
NM_006350 FST −13.72 Follistatin Development; negative regulation of follicle-stimulating
hormone secretion
NM_004245 TGM5 −13.40 Transglutaminase 5 Epidermis development; peptide cross-linking
AL512713 DKFZp762K222 −13.25 Similar to hypothetical protein
dkfzp762k222 (LOC401163), mrna
NM_032649 CPGL2 −13.18 Carnosinase 1 Proteolysis and peptidolysis
NM_022817 PER2 −12.79 Period homolog 2 (Drosophila) Circadian rhythm; regulation of transcription,
DNA-dependent; signal transduction
NM_012453 TBL2 −11.59 Transducin (beta)-like 2 Biological_process unknown
NM_025019 TUBA4 −11.55 Tubulin, alpha 4 Microtubule-based movement
AL133096 DNAJA4 −11.42 Dnaj (Hsp40) homolog, subfamily A, member 4 Protein folding
AK000470 LOC286434 −11.14 Homo sapiens cdna FLJ20463 fis, clone KAT06143.
NM_024410 ODF1 −10.95 Outer dense fiber of sperm tails 1 Spermatogenesis
NM_000448 RAG1 −10.81 Recombination activating gene 1 DNA recombination; hemocyte development;
immune response
AB075834 KIAA1954; −10.75 Zinc finger protein 90 homolog (mouse)
NM_003635 NDST2 −10.26 N-deacetylase/N-sulfotransferase
(heparan glucosaminyl) 2
BF089733 NRXN3 −10.01 Neurexin 3
NM_000451 SHOX −9.90 Short stature homeobox Development; regulation of transcription,
DNA-dependent; skeletal development;
transcription from Pol II promoter
BC005107 LOC90625 −9.71 Chromosome 21 open reading frame 105
NM_001215 CA6 −9.62 Carbonic anhydrase VI One-carbon compound metabolism
NM_001917 DAO −9.52 D-amino-acid oxidase Electron transport
NM_138569 MGC18257 −9.43 Chromosome 6 open reading frame 142
NM_024727 FLJ23259 −9.43 Hypothetical protein FLJ23259
NM_021946 FLJ11362 −9.35 Hypothetical protein FLJ11362
NM_001170 AQP7 −9.26 Aquaporin 7 Energy pathways; excretion; glycerol transport;
water transport
BC007251 MGC15504 −8.26 Chromosome 14 open reading frame 128
NM_005013 NUCB2 −7.94 Nucleobindin 2
NM_000328 RPGR −7.81 Retinitis pigmentosa gtpase regulator Intracellular protein transport; perception of sound;
visual perception
AL137763 LOC57822 −7.19 Sister-of-mammalian grainyhead
AY008283 PORIMIN −7.09 Pro-oncosis receptor inducing
membrane injury gene
NM_000700 ANXA1 −6.99 Annexin A1 Cell motility; cell surface receptor linked
signal transduction; inflammatory response;
lipid metabolism
NM_014244 ADAMTS2 −6.49 A disintegrin-like and metalloprotease
(reprolysin type) with thrombospondin
type 1 motif, 2
Collagen catabolism
NM_000602 SERPINE1 −6.29 Serine (or cysteine) proteinase inhibitor,
clade E (nexin, plasminogen activator
inhibitor type 1), member 1
Blood coagulation
X05299 CENPB −6.25 Centromere protein B, 80 kDa Centromere/kinetochore complex maturation
NM_002559 P2RX3 −6.02 Purinergic receptor P2X, ligand-gated
ion channel, 3
Ion transport; signal transduction
NM_015900 PS-PLA1 −5.95 Phospholipase A1 member A Lipid metabolism; phosphatidylserine metabolism
NM_016629 LOC51323 −5.81 Synonyms: DR6, BM-018; death receptor 6;
TNFR-related death receptor 6; Homo sapiens
tumor necrosis factor receptor superfamily,
member 21 (TNFRSF21), mrna.
NM_018641 C4S2 −5.59 Carbohydrate (chondroitin 4) sulfotransferase 12 Dermatan sulfate biosynthesis
NM_024106 MGC2663 −5.59 Zinc finger protein 426 Regulation of transcription, DNA-dependent
AK055449 FLJ11588 −5.49 Hypothetical protein FLJ11588
NM_001615 ACTG2 −5.43 Actin, gamma 2, smooth muscle, enteric Muscle development
NM_003287 TPD52L1 −5.29 Tumor protein D52-like 1 Biological_process unknown

Discussion

In this study, melanoma was used as a model system to systematically investigate the expression differences among snap frozen melanoma specimens, its derived primary culture cell lines and tumor xenografts by high throughput gene expression profiling analysis. Some genes those were concordant in all the models and many other genes that were differentially regulated were identified. Based on the clustering analysis, the expression profiles of the melanoma cell lines and the xenografts had more similarities than the profile of the snap frozen tumor tissue (Figures 1-3). It may be due to the heterogeneity of the tumor tissue despite the fact that over 90% of the cells were confirmed to be melanoma. This may also reflect the true intrinsic differences of gene expression between in vitro and in vivo models. Correlation analysis revealed that the best correlation was between the cell lines and the xenografts (Figures 4B and 5B). The correlation between the cell lines and the tumor tissues was the weakest among the three comparisons (Figures 4A and 5A). A fairly high degree of gene concordance was identified between the samples, ranging from 50-80% which may provide a selection of genes for careful examination in the future for clinical correlation with patient outcomes.

To further validate this approach, a pair of well characterized melanoma cell lines FEMX-I and FEMX-V were involved this study (17). The comparison of genes expression levels between their cultured cell lines and established corresponding tumor xenografts were analyzed base on the genes profiling. No significant differences in cellular proliferation, motility, migration or invasive capacity were identified under normal culture conditions. This may reflect differences of the influence of the tumor microenvironment in vivo and the unique properties of intercellular communication during the process of tumor cell proliferation and metastasis. In order to discover genes that may be responsible for such differences, the expression profiles of the melanoma cells and the tumor xenografts. Our data revealed that there were only 101 overlapping genes between the xenografts and the cell lines (Table I), with 239 differentially expressed genes in the cell lines (Table II) and 553 uniquely expressed genes in the xenografts (Table III). Many of these genes function as cell adhesion molecules such as JAM3, connexin-43 and growth factor binding proteins such as FIBP and IGFBP-5. Someof these genes may contribute to the phenotypic differences in vivo in terms of metastatic potential. Among these genes, connexin-43 expression was found to be no different between the two cell lines, however, it was over expressed over 400-fold in the metastatic tumor xenografts (Table III). Adhesion to vascular endothelium is a crucial first step in the colonization of select target organs by blood-borne cancer cells, and connexin-43 appears to represent an important gap junction protein, having a possible further function in angiogenesis and metastasis in melanoma, glioma, colon, lung and breast cancer (23-28). It has also been suggested that gap junction proteins such as connexin-43 may contribute to a more aggressive tumor cell phenotype via the loss of normal homeostatic growth regulation. A further understanding of this mechanism may provide new insights into the pathogenesis of human melanoma (29, 30). Thus, the high in vivo expression of connexin-43 in FEMX-I compared to FEMX-V tumors may reflect the differences in metastatic capacity. These examples demonstrate how such models may be used for gene profiling studies to identify progression-associated genes in melanoma. Furthermore it may help us to distinguish between genes expressed as a result of interactions within the microenvironment in which the cells grow. In this regard, novel genomic approaches provide a unique platform to explore genes that may play a key role in melanoma tumorigenesis and metastasis, possibly leading to targeted therapeutic approaches and gene discovery in melanoma research.

Acknowledgements

This study was supported in part by Mitchell Cancer Institute start-up fund (J. Ju), NIHR21CA114043 (J. Ju) and NIHR01MH075020 (J. Ju).

References

  • 1.Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117–122. doi: 10.1038/nature03664. [DOI] [PubMed] [Google Scholar]
  • 2.Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, Flotte TJ, Duncan LM, Granter SR, Chin L. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006;125:1269–1281. doi: 10.1016/j.cell.2006.06.008. [DOI] [PubMed] [Google Scholar]
  • 3.Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O’Rourke MG, Parsons PG, Meltzer P, Ringner M, Hayward NK. Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene. 2004;23:4060–4067. doi: 10.1038/sj.onc.1207563. [DOI] [PubMed] [Google Scholar]
  • 4.Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19–20. doi: 10.1038/ng1054. [DOI] [PubMed] [Google Scholar]
  • 5.Pollock PM, Meltzer PS. A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell. 2002;2:5–7. doi: 10.1016/s1535-6108(02)00089-2. [DOI] [PubMed] [Google Scholar]
  • 6.Acton EM, Narayanan VL, Risbood PA, Shoemaker RH, Vistica DT, Boyd MR. Anticancer specificity of some ellipticinium salts against human brain tumors in vitro. J Med Chem. 1994;37:2185–2189. doi: 10.1021/jm00040a010. [DOI] [PubMed] [Google Scholar]
  • 7.Beutler JA, Cardellina JH, 2nd, Gray GN, Prather TR, Shoemaker RH, Boyd MR, Lin CM, Hamel E, Cragg GM. Two new cytotoxic chalcones from Calythropsis aurea. J Nat Prod. 1993;56:1718–1722. doi: 10.1021/np50100a009. [DOI] [PubMed] [Google Scholar]
  • 8.Erickson KL, Beutler JA, Gray GN, Cardellina JH, 2nd, Boyd MR. Majapolene A, a cytotoxic peroxide, and related sesquiterpenes from the red alga Laurencia majuscula. J Nat Prod. 1995;58:1848–1860. doi: 10.1021/np50126a007. [DOI] [PubMed] [Google Scholar]
  • 9.Boyd MR, Farina C, Belfiore P, Gagliardi S, Kim JW, Hayakawa Y, Beutler JA, McKee TC, Bowman BJ, Bowman EJ. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. J Pharmacol Exp Ther. 2001;297:114–120. [PubMed] [Google Scholar]
  • 10.Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E, 3rd, Liotta LA, Weinstein JN. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci USA. 2003;100:14229–14234. doi: 10.1073/pnas.2331323100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Staunton JE, Slonim DK, Coller HA, Tamayo P, Angelo MJ, Park J, Scherf U, Lee JK, Reinhold WO, Weinstein JN, Mesirov JP, Lander ES, Golub TR. Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA. 2001;98:10787–10792. doi: 10.1073/pnas.191368598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Weinstein JN. Spotlight on molecular profiling: “Integromic” analysis of the NCI-60 cancer cell lines. Mol Cancer Ther. 2006;5:2601–2605. doi: 10.1158/1535-7163.MCT-06-0640. [DOI] [PubMed] [Google Scholar]
  • 13.Weinstein JN, Pommier Y. Transcriptomic analysis of the NCI-60 cancer cell lines. C R Biol. 2003;326:909–920. doi: 10.1016/j.crvi.2003.08.005. [DOI] [PubMed] [Google Scholar]
  • 14.Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17–32. doi: 10.1016/j.ccr.2004.06.010. [DOI] [PubMed] [Google Scholar]
  • 15.Lo M, Bulach DM, Powell DR, Haake DA, Matsunaga J, Paustian ML, Zuerner RL, Adler B. Effects of temperature on gene expression patterns in Leptospira interrogans serovar Lai as assessed by whole-genome microarrays. Infect Immun. 2006;74:5848–5859. doi: 10.1128/IAI.00755-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mazzatti DJ, White A, Forsey RJ, Powell JR, Pawelec G. Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence. Aging Cell. 2007;6:155–163. doi: 10.1111/j.1474-9726.2007.00269.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fodstad O, Kjonniksen I. Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis. J Cell Biochem. 1994;56:23–28. doi: 10.1002/jcb.240560106. [DOI] [PubMed] [Google Scholar]
  • 18.Riker A. The isolation and culture of melanoma cell lines. In: Langdon S, editor. Cancer Cell Culture. Humana Press; Totowa: 2004. pp. 93–100. [Google Scholar]
  • 19.Riker AI, Panelli MC, Kammula US, Wang E, Wunderlich J, Abati A, Fetsch P, Rosenberg SA, Marincola FM. Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma. Cancer Detect Prev. 1999;23:387–396. doi: 10.1046/j.1525-1500.1999.99045.x. [DOI] [PubMed] [Google Scholar]
  • 20.Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res. 2002;273:229–239. doi: 10.1006/excr.2001.5452. [DOI] [PubMed] [Google Scholar]
  • 21.Xi Y, Nakajima G, Schmitz JC, Chu E, Ju J. Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics. 2006;7:68. doi: 10.1186/1471-2164-7-68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res. 2006;12:2014–2024. doi: 10.1158/1078-0432.CCR-05-1853. [DOI] [PubMed] [Google Scholar]
  • 23.Kamibayashi Y, Oyamada Y, Mori M, Oyamada M. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis. 1995;16:1287–1297. doi: 10.1093/carcin/16.6.1287. [DOI] [PubMed] [Google Scholar]
  • 24.Lin JH, Takano T, Cotrina ML, Arcuino G, Kang J, Liu S, Gao Q, Jiang L, Li F, Lichtenberg-Frate H, Haubrich S, Willecke K, Goldman SA, Nedergaard M. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci. 2002;22:4302–4311. doi: 10.1523/JNEUROSCI.22-11-04302.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Milde-Langosch K, Janke S, Wagner I, Schroder C, Streichert T, Bamberger AM, Janicke F, Loning T. Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility. Breast Cancer Res Treat. 2007 doi: 10.1007/s10549-007-9559-y. epub ahead of print. [DOI] [PubMed] [Google Scholar]
  • 26.Oliveira R, Christov C, Guillamo JS, de Bouard S, Palfi S, Venance L, Tardy M, Peschanski M. Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol. 2005;6:7. doi: 10.1186/1471-2121-6-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang W, Nwagwu C, Le DM, Yong VW, Song H, Couldwell WT. Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg. 2003;99:1039–1046. doi: 10.3171/jns.2003.99.6.1039. [DOI] [PubMed] [Google Scholar]
  • 28.Zhang W, Vaccariello MA, Wang Y, Alt-Holland A, Fusenig NE, Garlick JA. Escape from microenvironmental control and progression of intraepithelial neoplasia. Int J Cancer. 2005;116:885–893. doi: 10.1002/ijc.21103. [DOI] [PubMed] [Google Scholar]
  • 29.Hsu M, Andl T, Li G, Meinkoth JL, Herlyn M. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci. 2000;113(Pt 9):1535–1542. doi: 10.1242/jcs.113.9.1535. [DOI] [PubMed] [Google Scholar]
  • 30.Li G, Satyamoorthy K, Herlyn M. Dynamics of cell interactions and communications during melanoma development. Crit Rev Oral Biol Med. 2002;13:62–70. doi: 10.1177/154411130201300107. [DOI] [PubMed] [Google Scholar]

RESOURCES